US20160310018A1 - Systems and methods for estimating ischemia and blood flow characteristics from vessel geometry and physiology - Google Patents

Systems and methods for estimating ischemia and blood flow characteristics from vessel geometry and physiology Download PDF

Info

Publication number
US20160310018A1
US20160310018A1 US15/200,160 US201615200160A US2016310018A1 US 20160310018 A1 US20160310018 A1 US 20160310018A1 US 201615200160 A US201615200160 A US 201615200160A US 2016310018 A1 US2016310018 A1 US 2016310018A1
Authority
US
United States
Prior art keywords
machine learning
learning algorithm
patient
plaque
interest
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US15/200,160
Inventor
Timothy FONTE
Gilwoo Choi
Leo Grady
Michael Singer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HeartFlow Inc
Original Assignee
HeartFlow Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HeartFlow Inc filed Critical HeartFlow Inc
Priority to US15/200,160 priority Critical patent/US20160310018A1/en
Assigned to HEARTFLOW, INC. reassignment HEARTFLOW, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: GRADY, LEO, FONTE, TIMOTHY, CHOI, GILWOO, SINGER, MICHAEL A.
Publication of US20160310018A1 publication Critical patent/US20160310018A1/en
Assigned to HAYFIN SERVICES LLP reassignment HAYFIN SERVICES LLP SECURITY INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: HEARTFLOW, INC.
Assigned to HEARTFLOW, INC. reassignment HEARTFLOW, INC. RELEASE BY SECURED PARTY (SEE DOCUMENT FOR DETAILS). Assignors: HAYFIN SERVICES LLP
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/02Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/026Measuring blood flow
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/0002Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
    • A61B5/0015Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network characterised by features of the telemetry system
    • A61B5/0022Monitoring a patient using a global network, e.g. telephone networks, internet
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/02Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/02007Evaluating blood vessel condition, e.g. elasticity, compliance
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/02Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/0205Simultaneously evaluating both cardiovascular conditions and different types of body conditions, e.g. heart and respiratory condition
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/02Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/021Measuring pressure in heart or blood vessels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/103Detecting, measuring or recording devices for testing the shape, pattern, colour, size or movement of the body or parts thereof, for diagnostic purposes
    • A61B5/107Measuring physical dimensions, e.g. size of the entire body or parts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14535Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring haematocrit
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14546Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring analytes not otherwise provided for, e.g. ions, cytochromes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/72Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7235Details of waveform analysis
    • A61B5/7264Classification of physiological signals or data, e.g. using neural networks, statistical classifiers, expert systems or fuzzy systems
    • A61B5/7267Classification of physiological signals or data, e.g. using neural networks, statistical classifiers, expert systems or fuzzy systems involving training the classification device
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/72Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7271Specific aspects of physiological measurement analysis
    • A61B5/7278Artificial waveform generation or derivation, e.g. synthesising signals from measured signals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/72Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7271Specific aspects of physiological measurement analysis
    • A61B5/7282Event detection, e.g. detecting unique waveforms indicative of a medical condition
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/74Details of notification to user or communication with user or patient ; user input means
    • A61B5/742Details of notification to user or communication with user or patient ; user input means using visual displays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/74Details of notification to user or communication with user or patient ; user input means
    • A61B5/742Details of notification to user or communication with user or patient ; user input means using visual displays
    • A61B5/743Displaying an image simultaneously with additional graphical information, e.g. symbols, charts, function plots
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
    • A61B6/02Arrangements for diagnosis sequentially in different planes; Stereoscopic radiation diagnosis
    • A61B6/03Computed tomography [CT]
    • A61B6/032Transmission computed tomography [CT]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
    • A61B6/46Arrangements for interfacing with the operator or the patient
    • A61B6/461Displaying means of special interest
    • A61B6/463Displaying means of special interest characterised by displaying multiple images or images and diagnostic data on one display
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
    • A61B6/50Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment specially adapted for specific body parts; specially adapted for specific clinical applications
    • A61B6/504Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment specially adapted for specific body parts; specially adapted for specific clinical applications for diagnosis of blood vessels, e.g. by angiography
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
    • A61B6/50Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment specially adapted for specific body parts; specially adapted for specific clinical applications
    • A61B6/507Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment specially adapted for specific body parts; specially adapted for specific clinical applications for determination of haemodynamic parameters, e.g. perfusion CT
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
    • A61B6/52Devices using data or image processing specially adapted for radiation diagnosis
    • A61B6/5211Devices using data or image processing specially adapted for radiation diagnosis involving processing of medical diagnostic data
    • A61B6/5217Devices using data or image processing specially adapted for radiation diagnosis involving processing of medical diagnostic data extracting a diagnostic or physiological parameter from medical diagnostic data
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
    • A61B6/56Details of data transmission or power supply, e.g. use of slip rings
    • A61B6/563Details of data transmission or power supply, e.g. use of slip rings involving image data transmission via a network
    • GPHYSICS
    • G06COMPUTING; CALCULATING OR COUNTING
    • G06NCOMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
    • G06N20/00Machine learning
    • GPHYSICS
    • G06COMPUTING; CALCULATING OR COUNTING
    • G06NCOMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
    • G06N7/00Computing arrangements based on specific mathematical models
    • G06N7/01Probabilistic graphical models, e.g. probabilistic networks
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2560/00Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
    • A61B2560/04Constructional details of apparatus
    • A61B2560/0475Special features of memory means, e.g. removable memory cards
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/02Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/024Detecting, measuring or recording pulse rate or heart rate

Definitions

  • Various embodiments of the present disclosure relate generally to medical imaging and related methods. More specifically, particular embodiments of the present disclosure relate to systems and methods for estimating patient-specific blood flow characteristics from vessel geometry and physiology.
  • embodiments of the present disclosure relate to rapid estimation of ischemia, blood flow, fractional flow reserve (FFR), or other metrics derived from patient-specific anatomy and characteristics to aid physicians in the diagnosis, management, and treatment of cardiovascular diseases.
  • FFR fractional flow reserve
  • Cardiovascular diseases are the leading cause of death in the industrialized world and contribute to roughly a third of global deaths.
  • the predominant form of acquired cardiovascular disease, atherosclerosis results from the chronic buildup of fatty material in the inner layer of the arteries supplying the heart, brain, kidneys, digestive system, and lower extremities.
  • Progressive coronary artery disease restricts blood flow to the heart, presenting as chest pain during physical exertion, referred to as chronic stable angina, or when the patient is at rest, known as unstable angina. More severe manifestation of disease may lead to myocardial infarction, or heart attack.
  • Noninvasive tests including ECG, treadmill tests, SPECT, PET, and CT—none of which measure blood flow and provide only anatomic information or indirect indications of disease. Due to the lack of accurate functional information provided by current noninvasive tests, many patients require invasive catheter procedures to assess coronary blood flow. There is a pressing need for a noninvasive means to quantify blood flow in the human coronary arteries to assess the functional significance of diffuse and focal coronary artery disease. Additionally, there is a need to achieve rapid assessment of blood flow to enable use in emergency rooms, in-patient treatment, and onsite hospital use.
  • invasive imaging such as coronary angiography
  • Such a technology is also applicable to preventing, diagnosing, managing and treating disease in other portions of the cardiovascular system including the arteries of the neck, e.g. the carotid arteries, the arteries in the head, e.g. the cerebral arteries, the arteries in the abdomen, e.g. the abdominal aorta and its branches, the arteries in legs, e.g. the femoral and popliteal arteries.
  • a functional assessment of arterial capacity is important for treatment planning to address patient needs.
  • hemodynamic characteristics such as Fractional Flow Reserve (FFR)
  • FFR Fractional Flow Reserve
  • Conventional assessments of these hemodynamic characteristics use invasive catheterizations to directly measure blood flow characteristics, such as pressure and flow velocity.
  • these invasive measurement techniques present severe risks to the patient and significant costs to the healthcare system.
  • noninvasive tests To address the risks and costs associated with invasive measurement, a new generation of noninvasive tests have been developed to assess blood flow characteristics. These noninvasive tests use patient imaging (such as computed tomography (CT)) to determine a patient-specific geometric model of the blood vessels and this model is used computationally to simulate the blood flow using computational fluid dynamics (CFD) with appropriate physiological boundary conditions and parameters. Examples of inputs to these patient-specific boundary conditions include the patient's blood pressure, blood viscosity and the expected demand of blood from the supplied tissue (derived from scaling laws and a mass estimation of the supplied tissue from the patient imaging).
  • CT computed tomography
  • CFD computational fluid dynamics
  • Systems and methods are disclosed for deriving a patient-specific geometric model of a patient's blood vessels, and combining this geometry with the patient-specific physiological information and boundary conditions. Combined, these data may be used to estimate the patient's blood flow characteristics and predict clinically relevant quantities of interest (e.g., FFR).
  • the presently disclosed systems and methods offer advantages over physics-based simulation of blood flow to compute the quantity of interest, such as by instead using machine learning to predict the results of a physics-based simulation.
  • disclosed systems and methods involve two phases: first, a training phase in which a machine learning system is trained to predict one or more blood flow characteristics; and second, a production phase in which the machine learning system is used to produce one or more blood flow characteristics and clinically relevant quantities of interest. In the case of predicting multiple blood flow characteristics, this machine learning system can be applied for each blood flow characteristic and quantity of interest.
  • a method for determining individual-specific blood flow characteristics. The method includes acquiring, for each of a plurality of individuals, individual-specific anatomic data and blood flow characteristics of at least part of the individual's vascular system; executing a machine learning algorithm on the individual-specific anatomic data and blood flow characteristics for each of the plurality of individuals; relating, based on the executed machine learning algorithm, each individual's individual-specific anatomic data to functional estimates of blood flow characteristics; acquiring, for an individual, individual-specific anatomic data of at least part of the individual's vascular system; and for at least one point in the individual's individual-specific anatomic data, determining a blood flow characteristic of the individual, using relations from the step of relating individual-specific anatomic data to functional estimates of blood flow characteristics.
  • a system for determining individual-specific blood flow characteristics.
  • the system includes a data storage device storing instructions for estimating individual-specific blood flow characteristics; and a processor configured to execute the instructions to perform a method including the steps of: acquiring, for each of a plurality of individuals, individual-specific anatomic data and blood flow characteristics of at least part of the individual's vascular system; executing a machine learning algorithm on the individual-specific anatomic data and blood flow characteristics for each of the plurality of individuals; relating, based on the executed machine learning algorithm, each individual's individual-specific anatomic data to functional estimates of blood flow characteristics; acquiring, for an individual, individual-specific anatomic data of at least part of the individual's vascular system; and for at least one point in the individual's individual-specific anatomic data, determining a blood flow characteristic of the individual, using relations from the step of relating individual-specific anatomic data to functional estimates of blood flow characteristics.
  • a non-transitory computer-readable medium storing instructions that, when executed by a computer, cause the computer to perform a method including: acquiring, for each of a plurality of individuals, individual-specific anatomic data and blood flow characteristics of at least part of the individual's vascular system; executing a machine learning algorithm on the individual-specific anatomic data and blood flow characteristics for each of the plurality of individuals; relating, based on the executed machine learning algorithm, each individual's individual-specific anatomic data to functional estimates of blood flow characteristics; acquiring, for an individual, individual-specific anatomic data of at least part of the individual's vascular system; and for at least one point in the individual's individual-specific anatomic data, determining a blood flow characteristic of the individual, using relations from the step of relating individual-specific anatomic data to functional estimates of blood flow characteristics.
  • FIG. 1 is a block diagram of an exemplary system and network for estimating patient-specific blood flow characteristics from vessel geometry and physiological information, according to an exemplary embodiment of the present disclosure.
  • FIG. 2 is a block diagram of an exemplary method for estimating patient-specific blood flow characteristics from vessel geometry and physiological information, according to an exemplary embodiment of the present disclosure.
  • the present disclosure describes certain principles and embodiments for providing advantages over physics-based simulation of blood flow to compute patient-specific blood flow characteristics and clinically relevant quantities of interest.
  • the presently disclosed systems and methods may incorporate machine learning techniques to predict the results of a physics-based simulation.
  • the present disclosure describes an exemplary, less processing-intensive technique, which may involve modeling the fractional flow reserve (FFR) as a function of a patient's vascular cross-sectional area, diseased length, and boundary conditions.
  • the cross-sectional area may be calculated based on lumen segment and plaque segment, among other things.
  • the diseased length may be calculated based on plaque segment and stenosis location, among other things.
  • the boundary conditions may reflect patient-specific physiology, such as coronary flow (estimated from myocardial mass), outlet area, and hyperemic assumptions, to reflect that different patients have different geometry and physiologic responses.
  • fractional flow reserve may be modeled as a function of a patient's boundary conditions (f(BCs)), and a function of a patient's vascular geometry (g(areaReductions)).
  • f(BCs) a patient's boundary conditions
  • g(areaReductions) a function of a patient's vascular geometry
  • FFR can be predicted by optimizing the functions “f” and “g” such that the difference between the estimated FFR (FFR CT _ ScalingLaw ) and the measured FFR (mFFR) is minimized.
  • machine learning techniques can be used to solve for the functions that cause the estimated FFR to approximate the measured FFR.
  • the measured FFR may be calculated by traditional catheterized methods or by modern, computational fluid dynamics (CFD) techniques.
  • CFD computational fluid dynamics
  • one or more machine learning algorithms may be used to optimize the functions of boundary conditions and patient geometry for hundreds or even thousands of patients, such that estimates for FFR can reliably approximate measured FFR values.
  • FFR values calculated by CFD techniques can be valuable for training the machine learning algorithms.
  • FIG. 1 depicts a block diagram of an exemplary system and network for estimating patient-specific blood flow characteristics from vessel geometry and physiological information.
  • FIG. 1 depicts a plurality of physicians 102 and third party providers 104 , any of whom may be connected to an electronic network 100 , such as the Internet, through one or more computers, servers, and/or handheld mobile devices.
  • Physicians 102 and/or third party providers 104 may create or otherwise obtain images of one or more patients' cardiac and/or vascular systems.
  • the physicians 102 and/or third party providers 104 may also obtain any combination of patient-specific information, such as age, medical history, blood pressure, blood viscosity, etc.
  • Physicians 102 and/or third party providers 104 may transmit the cardiac/vascular images and/or patient-specific information to server systems 106 over the electronic network 100 .
  • Server systems 106 may include storage devices for storing images and data received from physicians 102 and/or third party providers 104 .
  • Sever systems 106 may also include processing devices for processing images and data stored in the storage devices.
  • FIG. 2 is a block diagram of an exemplary method for estimating patient-specific blood flow characteristics from vessel geometry and physiological information, according to an exemplary embodiment of the present disclosure.
  • the method of FIG. 2 may be performed by server systems 106 , based on information received from physicians 102 and/or third party providers 104 over electronic network 100 .
  • the method of FIG. 2 may include a training method 202 , for training one or more machine learning algorithms based on numerous patients' blood flow characteristic estimates, and a production method 204 for using the machine learning algorithm results to predict a particular patient's blood flow characteristics.
  • training method 202 may be performed based on FFR estimates generating using CFD techniques for hundreds of patients. Training method 202 may involve acquiring, for each of a plurality of individuals, e.g., in digital format: (a) a patient-specific geometric model, (b) one or more measured or estimated physiological parameters, and (c) values of blood flow characteristics. Training method 202 may then involve, for one or more points in each patient's model, creating a feature vector of the patients' physiological parameters and associating the feature vector with the values of blood flow characteristics. For example, training method 202 may associate an estimated FFR with every point in a patient's geometric model.
  • Training method 202 may then train a machine learning algorithm (e.g., using processing devices of server systems 106 ) to predict blood flow characteristics at each point of a geometric model, based on the feature vectors and blood flow characteristics. Training method 202 may then save the results of the machine learning algorithm, including feature weights, in a storage device of server systems 106 .
  • the stored feature weights may define the extent to which patient features or geometry are predictive of certain blood flow characteristics.
  • the production method 204 may involve estimating FFR values for a particular patient, based on results of executing training method 202 .
  • production method 204 may include acquiring, e.g. in digital format: (a) a patient-specific geometric model, and (b) one or more measured or estimated physiological parameters. For multiple points in the patient's geometric model, production method 204 may involve creating a feature vector of the physiological parameters used in the training mode. Production method 204 may then use saved results of the machine learning algorithm to produce estimates of the patient's blood flow characteristics for each point in the patient-specific geometric model. Finally, production method 204 may include saving the results of the machine learning algorithm, including predicted blood flow characteristics, to a storage device of server systems 106 .
  • Described below are general and specific exemplary embodiments for implementing a training mode and a production mode of machine learning for predicting patient-specific blood flow characteristics, e.g. using server systems 106 based on images and data received from physicians 102 and/or third party providers 104 over electronic network 100 .
  • server systems 106 may perform a training mode based on images and data received from physicians 102 and/or third party providers 104 over electronic network 100 . Specifically, for one or more patients, server systems 106 may acquire a digital representation (e.g., the memory or digital storage [e.g., hard drive, network drive] of a computational device such as a computer, laptop, DSP, server, etc.) of the following items: (a) a patient-specific model of the geometry for one or more of the patient's blood vessels; (b) a list of one or more measured or estimated physiological or phenotypic parameters of the patient; and/or (c) measurements, estimations or simulated values of all blood flow characteristic being targeted for prediction.
  • a digital representation e.g., the memory or digital storage [e.g., hard drive, network drive] of a computational device such as a computer, laptop, DSP, server, etc.
  • a digital representation e.g., the memory or digital storage [e.g., hard drive, network drive]
  • the patient-specific model of the geometry may be represented by a list of points in space (possibly with a list of neighbors for each point) in which the space can be mapped to spatial units between points (e.g., millimeters).
  • the list of one or more measured or estimated physiological or phenotypic parameters of the patient may include blood pressure, blood viscosity, patient age, patient gender, mass of the supplied tissue, etc. These patient-specific parameters may be global (e.g., blood pressure) or local (e.g., estimated density of the vessel wall at a particular location).
  • server systems 106 may then create a feature vector for that point.
  • the feature vector may be a numerical description of the patient-specific geometry at that point and estimates of physiological or phenotypic parameters of the patient.
  • the feature vector may contain both global and local physiological or phenotypic parameters, where: for global parameters, all points have the same numerical value; and for local parameters, the value(s) may change at different points in the feature vector.
  • Server systems 106 may then associate this feature vector with the measured, estimated or simulated value of the blood flow characteristic at this point.
  • Server systems 106 may then train a machine learning algorithm to predict the blood flow characteristics at the points from the feature vectors at the points.
  • machine learning algorithms that can perform this task are support vector machines (SVMs), multi-layer perceptrons (MLPs), and multivariate regression (MVR) (e.g., weighted linear or logistic regression).
  • Server systems 106 may then save the results of the machine learning algorithm (e.g., feature weights) to a digital representation (e.g., the memory or digital storage [e.g., hard drive, network drive] of a computational device such as a computer, laptop, DSP, server, etc.).
  • a digital representation e.g., the memory or digital storage [e.g., hard drive, network drive] of a computational device such as a computer, laptop, DSP, server, etc.
  • server systems 106 may perform a production mode based on images and data received from physicians 102 and/or third party providers 104 over electronic network 100 .
  • server systems 106 may acquire a digital representation (e.g., the memory or digital storage [e.g., hard drive, network drive] of a computational device such as a computer, laptop, DSP, server, etc.) of (a) a patient-specific model of the geometry for one or more of the patient's blood vessels; and (b) a list of one or more estimates of physiological or phenotypic parameters of the patient.
  • a digital representation e.g., the memory or digital storage [e.g., hard drive, network drive] of a computational device such as a computer, laptop, DSP, server, etc.
  • the patient-specific model of the geometry for one or more of the patient's blood vessels may be represented as a list of points in space (possibly with a list of neighbors for each point) in which the space can be mapped to spatial units between points (e.g., millimeters).
  • the list of one or more estimates of physiological or phenotypic parameters of the patient may include blood pressure, blood viscosity, patient age, patient gender, the mass of the supplied tissue, etc. These parameters may be global (e.g., blood pressure) or local (e.g., estimated density of the vessel wall at a location). This list of parameters must be the same as the list used in the training mode.
  • server systems 106 may create a feature vector that consists of a numerical description of the geometry and estimates of physiological or phenotypic parameters of the patient.
  • Global physiological or phenotypic parameters can be used in the feature vector of all points and local physiological or phenotypic parameters can change in the feature vector of different points.
  • These feature vectors may represent the same parameters used in the training mode.
  • Server systems 106 may then use the saved results of the machine learning algorithm produced in the training mode (e.g., feature weights) to produce estimates of the blood flow characteristics at each point in the patient-specific geometric model. These estimates may be produced using the same machine learning algorithm technique used in the training mode (e.g., the SVM, MLP, MVR technique).
  • Server systems 106 may also save the predicted blood flow characteristics for each point to a digital representation (e.g., the memory or digital storage [e.g., hard drive, network drive] of a computational device such as a computer, laptop, DSP, server, etc.).
  • a digital representation e.g., the memory or digital storage [e.g., hard drive, network drive] of a computational device such as a computer, laptop, DSP, server, etc.
  • server systems 106 may perform a training mode based on images and data received from physicians 102 and/or third party providers 104 over electronic network 100 . Specifically, for one or more patients, server systems 106 may acquire a digital representation (e.g., the memory or digital storage [e.g., hard drive, network drive] of a computational device such as a computer, laptop, DSP, server, etc.) of (a) a patient-specific model of the geometry for the patient's ascending aorta and coronary artery tree; (b) a list of measured or estimated physiological or phenotypic parameters of the patient; and (c) measurements of the FFR when available.
  • a digital representation e.g., the memory or digital storage [e.g., hard drive, network drive] of a computational device such as a computer, laptop, DSP, server, etc.
  • a digital representation e.g., the memory or digital storage [e.g., hard drive, network drive] of a computational device such as a computer, laptop
  • the patient-specific model of the geometry for the patient's ascending aorta and coronary artery tree may be represented as a list of points in space (possibly with a list of neighbors for each point) in which the space can be mapped to spatial units between points (e.g., millimeters).
  • This model may be derived by performing a cardiac CT imaging study of the patient during the end diastole phase of the cardiac cycle. The resulting CT images may then be segmented manually or automatically to identify voxels belonging to the aorta and to the lumen of the coronary arteries. Once all relevant voxels are identified, the geometric model can be derived (e.g., using marching cubes).
  • the list of measured or estimated physiological or phenotypic parameters of the patient may be obtained and may include: (i) systolic and diastolic blood pressures; (ii) heart rate; (iii) hematocrit level; (iv) patient age, gender, height, weight, general health status (presence or absence of diabetes, current medications); (v) lifestyle characteristics: smoker/non-smoker; and/or (vi) myocardial mass (may be derived by segmenting the myocardium obtained during the CT imaging study and then calculating the volume in the image; the mass is then computed using the computed volume and an estimated density (1.05 g/mL) of the myocardial mass.
  • measurements of the FFR may be obtained when available. If the measured FFR value is not available at a given spatial location in the patient-specific geometric model, then a numerically computed value of the FFR at the point may be used. The numerically computed values may be obtained from a previous CFD simulation using the same geometric model and patient-specific boundary conditions derived from the physiological and phenotypic parameters listed above.
  • server systems 106 may create a feature vector for that point that contains a numerical description of physiological or phenotypic parameters of the patient and a description of the local geometry.
  • the feature vector may contain: (i) systolic and diastolic blood pressures; (ii) heart rate; (iii) blood properties including: plasma, red blood cells (erythrocytes), hematocrit, white blood cells (leukocytes) and platelets (thrombocytes), viscosity, yield stress; (iv) patient age, gender, height, weight, etc.; (v) diseases: presence or absence of diabetes, myocardial infarction, malignant and rheumatic conditions, peripheral vascular conditions, etc.; (vi) lifestyle characteristics: presence or absence of current medications/drugs, smoker/non-smoker; (vii) characteristics of the aortic geometry (Cross-sectional area of the aortic inlet and outlet, Surface area and volume of the aorta, Minimum, maximum, and average cross-sectional area, etc.); (viii) characteristics of the coronary branch geometry; and (ix) one or more feature sets.
  • blood properties including: plasma, red blood
  • the characteristics of the coronary branch geometry may include: (i) volumes of the aorta upstream/downstream of the coronary branch point; (ii) cross-sectional area of the coronary/aorta bifurcation point, i.e., inlet to the coronary branch; (iii) total number of vessel bifurcations, and the number of upstream/downstream vessel bifurcations; (iv) average, minimum, and maximum upstream/downstream cross-sectional areas; (v) distances (along the vessel centerline) to the centerline point of minimum and maximum upstream/downstream cross-sectional areas; (vi) cross-sectional of and distance (along the vessel centerline) to the nearest upstream/downstream vessel bifurcation; (vii) cross-sectional area of and distance (along the vessel centerline) to the nearest coronary outlet and aortic inlet/outlet; (viii) cross-sectional areas and distances (along the vessel centerline) to the downstream coronary outlets with the
  • a first feature set may define cross-sectional area features, such as a cross-sectional lumen area along the coronary centerline, a powered cross-sectional lumen area, a ratio of lumen cross-sectional area with respect to the main ostia (LM, RCA), a powered ratio of lumen cross-sectional area with respect to the main ostia, a degree of tapering in cross-sectional lumen area along the centerline, locations of stenotic lesions, lengths of stenotic lesions, location and number of lesions corresponding to 50%, 75%, 90% area reduction, distance from stenotic lesion to the main ostia, and/or irregularity (or circularity) of cross-sectional lumen boundary.
  • cross-sectional area features such as a cross-sectional lumen area along the coronary centerline, a powered cross-sectional lumen area, a ratio of lumen cross-sectional area with respect to the main ostia (LM, RCA), a powered ratio of lumen cross-sectional area
  • the cross-sectional lumen area along the coronary centerline may be calculated by extracting a centerline from constructed geometry, smoothing the centerline if necessary, and computing cross-sectional area at each centerline point and map it to corresponding surface and volume mesh points.
  • the powered cross-sectional lumen area can be determined from various source of scaling laws.
  • the ratio of lumen cross-sectional area with respect to the main ostia can be calculated by measuring cross-sectional area at the LM ostium, normalizing cross-sectional area of the left coronary by LM ostium area, measuring cross-sectional area at the RCA ostium, and normalizing cross-sectional area of the right coronary by RCA ostium area.
  • the powered ratio of lumen cross-sectional area with respect to the main ostia can be determined from various source of scaling laws.
  • the degree of tapering in cross-sectional lumen area along the centerline can be calculated by sampling centerline points within a certain interval (e.g., twice the diameter of the vessel) and compute a slope of linearly-fitted cross-sectional area.
  • the location of stenotic lesions can be calculated by detecting minima of cross-sectional area curve, detecting locations where first derivative of area curve is zero and second derivative is positive, and computing distance (parametric arc length of centerline) from the main ostium.
  • the lengths of stenotic lesions can be calculated by computing the proximal and distal locations from the stenotic lesion, where cross-sectional area is recovered.
  • another feature set may include intensity features that define, for example, intensity change along the centerline (slope of linearly-fitted intensity variation).
  • another feature set may include surface features that define, for example, 3D surface curvature of geometry (Gaussian, maximum, minimum, mean).
  • another feature set may include volume features that define, for example, a ratio of total coronary volume compared to myocardial volume.
  • another feature set may include centerline features that define, for example, curvature (bending) of coronary centerline, e.g., by computing Frenet curvature:
  • Curvature (bending) of coronary centerline may also be calculated based on tortuosity (non-planarity) of coronary centerline, e.g., by computing Frenet torsion:
  • another feature set may include a SYNTAX scoring feature, including, for example, an existence of aorto ostial lesion, detection of a lesion located at the origin of the coronary from the aorta; and/or dominance (left or right).
  • SYNTAX scoring feature including, for example, an existence of aorto ostial lesion, detection of a lesion located at the origin of the coronary from the aorta; and/or dominance (left or right).
  • another feature set may include a simplified physics feature, e.g., including a fractional flow reserve value derived from Hagen-Poisseille flow assumption (Resistance ⁇ Area ⁇ 2 ).
  • server systems 106 may compute the cross-sectional area of the origin (LM ostium or RCA ostium) of the coronary from the aorta (A 0 ) with aortic pressure (P 0 ); compute cross-sectional area of coronary vessel (A i ) at each sampled interval (L i ); determine the amount of coronary flow in each segment of vessel using resistance boundary condition under hyperemic assumption (Q i ); estimate resistance at each sampled location (R i ) based on:
  • R i ⁇ i ⁇ 8 ⁇ ⁇ ⁇ ⁇ L i ⁇ ⁇ ⁇ A i ⁇ i + ⁇ i ,
  • Server systems 106 may interpolate FFR along the centerline using FFR i , project FFR values to 3D surface mesh node, and vary ⁇ i , ⁇ i , ⁇ i and obtain new sets of FFR estimation as necessary for training, such as by using the feature sets defined above to perturb parameters where ⁇ i , ⁇ i can be a function of the diseased length, degree of stenosis and tapering ratio to account for tapered vessel; and Q i can be determined by summing distributed flow of each outlet on the basis of the same scaling law as the resistance boundary condition (outlet resistance ⁇ outlet area ⁇ 1.35 ).
  • Server systems 106 may also train a linear SVM to predict the blood flow characteristics at the points from the feature vectors at the points; and save the results of the SVM as a digital representation (e.g., the memory or digital storage [e.g., hard drive, network drive] of a computational device such as a computer, laptop, DSP, server, etc.).
  • a digital representation e.g., the memory or digital storage [e.g., hard drive, network drive] of a computational device such as a computer, laptop, DSP, server, etc.
  • servers systems 106 may, for a target patient, acquire in digital representation (e.g., the memory or digital storage (e.g., hard drive, network drive) of a computational device such as a computer, laptop, DSP, server, etc.): (a) a patient-specific model of the geometry for the patient's ascending aorta and coronary artery tree; and (b) a list of physiological and phenotypic parameters of the patient obtained during training mode.
  • digital representation e.g., the memory or digital storage (e.g., hard drive, network drive) of a computational device such as a computer, laptop, DSP, server, etc.
  • the patient-specific model of the geometry for the patient's ascending aorta and coronary artery tree may be represented as a list of points in space (possibly with a list of neighbors for each point) in which the space can be mapped to spatial units between points (e.g., millimeters).
  • This model may be derived by performing a cardiac CT imaging of the patient in the end diastole phase of the cardiac cycle. This image then may be segmented manually or automatically to identify voxels belonging to the aorta and the lumen of the coronary arteries. Once the voxels are identified, the geometric model can be derived (e.g., using marching cubes).
  • the process for generating the patient-specific model of the geometry may be the same as in the training mode.
  • the server systems 106 may create a feature vector for that point that consists of a numerical description of the geometry at that point and estimates of physiological or phenotypic parameters of the patient. These features may be the same as the quantities used in the training mode.
  • the server systems 106 may then use the saved results of the machine learning algorithm produced in the training mode (e.g., feature weights) to produce estimates of the FFR at each point in the patient-specific geometric model. These estimates may be produced using the same linear SVM technique used in the training mode.
  • the server systems 106 may save the predicted FFR values for each point to a digital representation (e.g., the memory or digital storage [e.g., hard drive, network drive] of a computational device such as a computer, laptop, DSP, server, etc.).
  • a digital representation e.g., the memory or digital storage [e.g., hard drive, network drive] of a computational device such as a computer, laptop, DSP, server, etc.
  • the above factors (i) thru (viii) (“Systolic and diastolic blood pressures” thru “Characteristics of the coronary branch geometry”) may be considered global features, which are applicable to all points within a given patient's geometric model.
  • items (ix) thru (xv) (“Feature Set I: Cross-sectional area feature” thru “Feature Set VII: Simplified Physics feature”) may be considered features that are local to specific points within a given patient's geometric model.
  • features (i) thru (vi) may be considered variables within the function of boundary conditions, f(BCs)
  • features (vii) thru (xv) may be considered variables within the function of geometry, g(areaReductions), on that page. It will be appreciated that any combination of those features, modified by any desired weighting scheme, may be incorporated into a machine learning algorithm executed according to the disclosed embodiments.
  • systems and methods are described to obtain estimates of physiologic metrics, such as ischemia, blood flow, or FFR from patient-specific anatomy and characteristics.
  • the system may consist of a computer and software either on-site at a hospital or off-site that physicians load or transfer patient-specific data to.
  • the anatomic data may consist of imaging data (ie CT) or measurements and anatomic representation already obtained from imaging data (quantitative angiography, vessel segmentations from third party software, vascular diameters, etc).
  • Other patient characteristics may consist of heart rate, blood pressure, demographics such as age or sex, medication, disease states including diabetes and hypertension, prior MI, etc.
  • relevant data may be processed by software automation, the physician using the system, a third-party technician or analyst using the system, or any combination.
  • the data may be processed using algorithms relating the patient's anatomy and characteristics to functional estimates of ischemia and blood flow.
  • the algorithms may employ empirically derived models, machine learning, or analytical models relating blood flow to anatomy.
  • Estimates of ischemia (blood flow, FFR, etc) may be generated for a specific location in a vessel, as an overall estimate for the vessel, or for an entire system of vessels such as the coronary arteries.
  • a numeric output, such as an FFR value may be generated or simple positive/negative/inconclusive indications based on clinical metrics may be provided (ie FFR> or ⁇ 0.80).
  • Results of the analysis may be displayed or stored in a variety of media, including images, renderings, tables of values, or reports and may be transferred back to the physician through the system or through other electronic or physical delivery methods.
  • the algorithm to estimate FFR from patient anatomy consists of deriving an analytical model based on fundamentals of physiology and physics, for example analytical fluid dynamics equations and morphometry scaling laws.
  • Information about the following coronary anatomy including but not limited to the following features derived from imaging data (ie CT), serves as an input:
  • Pressure drop may be estimated by relating the amount of blood flow to the resistance to blood flow using any of a variety of analytical models, such as Poiseuille's equation, energy loss models, etc.
  • analytical models such as Poiseuille's equation, energy loss models, etc.
  • FFR ( P ⁇ P )/ P where P is the aortic pressure and ⁇ P is the change in pressure from the aorta to the location of interest.
  • the flow rate may be estimated by morphometry relations, such as Q ⁇ M k where M is the myocardial volume and k is an exponent, often approximately 0.75.
  • Individual vessel flow rates may scale based on the morphometry relationship of Q ⁇ D k where D is the diameter of the vessel and k is an exponent, often between 2 and 3.
  • the resistance through a vessel may be estimated by Poiseuille's equation:
  • Downstream, or microvascular resistances may be estimated through morphometric tree generation or other methods described in Ser. Nos. 13/014,809 and 08/157,742.
  • FFR can be estimated by relating all the resistance and flow estimates in a network representing the distribution of vessels in the coronary circulation, and pressure can be solved.
  • regression or machine learning may be employed to train the algorithm using the features previously mentioned, formulations of resistances and flows, and additional anatomic and patient characteristics, including but not limited to:
  • Disease state such as hypertension, diabetes, previous cardiac events
  • a library or database of anatomic and patient characteristics along with FFR, ischemia test results, previous simulation results, imaging data, or other metrics may be compiled. For every point of interest where an FFR estimation is required, a set of features may be generated.
  • a regression or machine learning technique such as linear regression or decision trees, may be used to define which features have the largest impact on estimating FFR and to create an algorithm that weights the various features.
  • Example embodiments may estimate FFR numerically, classify a vessel as ischemia positive or negative, or classify a patient as ischemia positive or negative.
  • an algorithm may be executed on new data provided by the physician to the system.
  • a number of methods may be used to generate the anatomic information required, and once obtained, the features defined, algorithm performed, and results reported.
  • a confidence from the machine learning algorithm may be provided.
  • One example embodiment is to report that a particular vessel in a patient has a specific percent confidence of being positive or negative for ischemia, ie Left anterior descending artery is positive with 85% confidence.
  • the algorithm may be refined or updated as additional patient data is added to the library or database.
  • One additional embodiment is to derive any of the previously mentioned parameters, physiologic, or physical estimations empirically. Coupled with machine learning or analytic techniques, empirical studies of flow and pressure across various geometries may be utilized to inform the algorithms.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Surgery (AREA)
  • Biophysics (AREA)
  • Physiology (AREA)
  • Optics & Photonics (AREA)
  • Radiology & Medical Imaging (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Artificial Intelligence (AREA)
  • Cardiology (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Theoretical Computer Science (AREA)
  • Vascular Medicine (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dentistry (AREA)
  • Signal Processing (AREA)
  • Psychiatry (AREA)
  • Data Mining & Analysis (AREA)
  • Mathematical Physics (AREA)
  • Evolutionary Computation (AREA)
  • Software Systems (AREA)
  • Pulmonology (AREA)
  • General Physics & Mathematics (AREA)
  • Computer Networks & Wireless Communication (AREA)
  • Epidemiology (AREA)
  • Primary Health Care (AREA)
  • Databases & Information Systems (AREA)
  • Computing Systems (AREA)

Abstract

Systems and methods are disclosed for determining individual-specific blood flow characteristics. One method includes acquiring, for each of a plurality of individuals, individual-specific anatomic data and blood flow characteristics of at least part of the individual's vascular system; executing a machine learning algorithm on the individual-specific anatomic data and blood flow characteristics for each of the plurality of individuals; relating, based on the executed machine learning algorithm, each individual's individual-specific anatomic data to functional estimates of blood flow characteristics; acquiring, for an individual and individual-specific anatomic data of at least part of the individual's vascular system; and for at least one point in the individual's individual-specific anatomic data, determining a blood flow characteristic of the individual, using relations from the step of relating individual-specific anatomic data to functional estimates of blood flow characteristics.

Description

    RELATED APPLICATION
  • This application claims priority to U.S. Provisional Application No. 61/700,213 filed Sep. 12, 2012, and 61/793,673, filed Mar. 15, 2013, the entire disclosures of which are hereby incorporated by reference in their entireties.
  • FIELD OF THE INVENTION
  • Various embodiments of the present disclosure relate generally to medical imaging and related methods. More specifically, particular embodiments of the present disclosure relate to systems and methods for estimating patient-specific blood flow characteristics from vessel geometry and physiology.
  • In addition, embodiments of the present disclosure relate to rapid estimation of ischemia, blood flow, fractional flow reserve (FFR), or other metrics derived from patient-specific anatomy and characteristics to aid physicians in the diagnosis, management, and treatment of cardiovascular diseases.
  • BACKGROUND
  • Cardiovascular diseases are the leading cause of death in the industrialized world and contribute to roughly a third of global deaths. The predominant form of acquired cardiovascular disease, atherosclerosis, results from the chronic buildup of fatty material in the inner layer of the arteries supplying the heart, brain, kidneys, digestive system, and lower extremities. Progressive coronary artery disease restricts blood flow to the heart, presenting as chest pain during physical exertion, referred to as chronic stable angina, or when the patient is at rest, known as unstable angina. More severe manifestation of disease may lead to myocardial infarction, or heart attack. Patients presenting with chest pain are usually subject to a range of currently available noninvasive tests, including ECG, treadmill tests, SPECT, PET, and CT—none of which measure blood flow and provide only anatomic information or indirect indications of disease. Due to the lack of accurate functional information provided by current noninvasive tests, many patients require invasive catheter procedures to assess coronary blood flow. There is a pressing need for a noninvasive means to quantify blood flow in the human coronary arteries to assess the functional significance of diffuse and focal coronary artery disease. Additionally, there is a need to achieve rapid assessment of blood flow to enable use in emergency rooms, in-patient treatment, and onsite hospital use. In addition to non-invasive use, there is a need within invasive imaging, such as coronary angiography, to quickly estimate functional metrics without the need for pressure or flow wires or special medication. Such a technology is also applicable to preventing, diagnosing, managing and treating disease in other portions of the cardiovascular system including the arteries of the neck, e.g. the carotid arteries, the arteries in the head, e.g. the cerebral arteries, the arteries in the abdomen, e.g. the abdominal aorta and its branches, the arteries in legs, e.g. the femoral and popliteal arteries.
  • A functional assessment of arterial capacity is important for treatment planning to address patient needs. Recent studies have demonstrated that hemodynamic characteristics, such as Fractional Flow Reserve (FFR), are important indicators to determine the optimal treatment for a patient with arterial disease. Conventional assessments of these hemodynamic characteristics use invasive catheterizations to directly measure blood flow characteristics, such as pressure and flow velocity. However, despite the important clinical information that is gathered, these invasive measurement techniques present severe risks to the patient and significant costs to the healthcare system.
  • To address the risks and costs associated with invasive measurement, a new generation of noninvasive tests have been developed to assess blood flow characteristics. These noninvasive tests use patient imaging (such as computed tomography (CT)) to determine a patient-specific geometric model of the blood vessels and this model is used computationally to simulate the blood flow using computational fluid dynamics (CFD) with appropriate physiological boundary conditions and parameters. Examples of inputs to these patient-specific boundary conditions include the patient's blood pressure, blood viscosity and the expected demand of blood from the supplied tissue (derived from scaling laws and a mass estimation of the supplied tissue from the patient imaging). Although these simulation-based estimations of blood flow characteristics have demonstrated a level of fidelity comparable to direct (invasive) measurements of the same quantity of interest, physical simulations demand a substantial computational burden that can make these virtual, noninvasive tests difficult to execute in a real-time clinical environment. Consequently, the present disclosure describes new approaches for performing rapid, noninvasive estimations of blood flow characteristics that are computationally inexpensive.
  • SUMMARY
  • Systems and methods are disclosed for deriving a patient-specific geometric model of a patient's blood vessels, and combining this geometry with the patient-specific physiological information and boundary conditions. Combined, these data may be used to estimate the patient's blood flow characteristics and predict clinically relevant quantities of interest (e.g., FFR). The presently disclosed systems and methods offer advantages over physics-based simulation of blood flow to compute the quantity of interest, such as by instead using machine learning to predict the results of a physics-based simulation. In one embodiment, disclosed systems and methods involve two phases: first, a training phase in which a machine learning system is trained to predict one or more blood flow characteristics; and second, a production phase in which the machine learning system is used to produce one or more blood flow characteristics and clinically relevant quantities of interest. In the case of predicting multiple blood flow characteristics, this machine learning system can be applied for each blood flow characteristic and quantity of interest.
  • According to one embodiment, a method is disclosed for determining individual-specific blood flow characteristics. The method includes acquiring, for each of a plurality of individuals, individual-specific anatomic data and blood flow characteristics of at least part of the individual's vascular system; executing a machine learning algorithm on the individual-specific anatomic data and blood flow characteristics for each of the plurality of individuals; relating, based on the executed machine learning algorithm, each individual's individual-specific anatomic data to functional estimates of blood flow characteristics; acquiring, for an individual, individual-specific anatomic data of at least part of the individual's vascular system; and for at least one point in the individual's individual-specific anatomic data, determining a blood flow characteristic of the individual, using relations from the step of relating individual-specific anatomic data to functional estimates of blood flow characteristics.
  • According to one embodiment, a system is disclosed for determining individual-specific blood flow characteristics. The system includes a data storage device storing instructions for estimating individual-specific blood flow characteristics; and a processor configured to execute the instructions to perform a method including the steps of: acquiring, for each of a plurality of individuals, individual-specific anatomic data and blood flow characteristics of at least part of the individual's vascular system; executing a machine learning algorithm on the individual-specific anatomic data and blood flow characteristics for each of the plurality of individuals; relating, based on the executed machine learning algorithm, each individual's individual-specific anatomic data to functional estimates of blood flow characteristics; acquiring, for an individual, individual-specific anatomic data of at least part of the individual's vascular system; and for at least one point in the individual's individual-specific anatomic data, determining a blood flow characteristic of the individual, using relations from the step of relating individual-specific anatomic data to functional estimates of blood flow characteristics.
  • According to one embodiment, a non-transitory computer-readable medium storing instructions that, when executed by a computer, cause the computer to perform a method including: acquiring, for each of a plurality of individuals, individual-specific anatomic data and blood flow characteristics of at least part of the individual's vascular system; executing a machine learning algorithm on the individual-specific anatomic data and blood flow characteristics for each of the plurality of individuals; relating, based on the executed machine learning algorithm, each individual's individual-specific anatomic data to functional estimates of blood flow characteristics; acquiring, for an individual, individual-specific anatomic data of at least part of the individual's vascular system; and for at least one point in the individual's individual-specific anatomic data, determining a blood flow characteristic of the individual, using relations from the step of relating individual-specific anatomic data to functional estimates of blood flow characteristics.
  • Additional objects and advantages of the disclosed embodiments will be set forth in part in the description that follows, and in part will be apparent from the description, or may be learned by practice of the disclosed embodiments. The objects and advantages of the disclosed embodiments will be realized and attained by means of the elements and combinations particularly pointed out in the appended claims.
  • It is to be understood that both the foregoing general description and the following detailed description are exemplary and explanatory only and are not restrictive of the disclosed embodiments, as claimed.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • The accompanying drawings, which are incorporated in and constitute a part of this specification, illustrate various exemplary embodiments and together with the description, serve to explain the principles of the disclosed embodiments.
  • FIG. 1 is a block diagram of an exemplary system and network for estimating patient-specific blood flow characteristics from vessel geometry and physiological information, according to an exemplary embodiment of the present disclosure.
  • FIG. 2 is a block diagram of an exemplary method for estimating patient-specific blood flow characteristics from vessel geometry and physiological information, according to an exemplary embodiment of the present disclosure.
  • DESCRIPTION OF THE EMBODIMENTS
  • Reference will now be made in detail to the exemplary embodiments of the disclosure, examples of which are illustrated in the accompanying drawings. Wherever possible, the same reference numbers will be used throughout the drawings to refer to the same or like parts.
  • The present disclosure describes certain principles and embodiments for providing advantages over physics-based simulation of blood flow to compute patient-specific blood flow characteristics and clinically relevant quantities of interest. Namely, the presently disclosed systems and methods may incorporate machine learning techniques to predict the results of a physics-based simulation. For example, the present disclosure describes an exemplary, less processing-intensive technique, which may involve modeling the fractional flow reserve (FFR) as a function of a patient's vascular cross-sectional area, diseased length, and boundary conditions. The cross-sectional area may be calculated based on lumen segment and plaque segment, among other things. The diseased length may be calculated based on plaque segment and stenosis location, among other things. The boundary conditions may reflect patient-specific physiology, such as coronary flow (estimated from myocardial mass), outlet area, and hyperemic assumptions, to reflect that different patients have different geometry and physiologic responses.
  • In one embodiment, fractional flow reserve may be modeled as a function of a patient's boundary conditions (f(BCs)), and a function of a patient's vascular geometry (g(areaReductions)). Although the patient's geometry may be described as a function of “areaReductions,” it should be appreciated that this term refers, not just to changes in patient's vascular cross-sectional area, but to any physical or geometric characteristics affecting a patient's blood flow. In one embodiment, FFR can be predicted by optimizing the functions “f” and “g” such that the difference between the estimated FFR (FFRCT _ ScalingLaw) and the measured FFR (mFFR) is minimized. In other words, machine learning techniques can be used to solve for the functions that cause the estimated FFR to approximate the measured FFR. In one embodiment, the measured FFR may be calculated by traditional catheterized methods or by modern, computational fluid dynamics (CFD) techniques. In one embodiment, one or more machine learning algorithms may be used to optimize the functions of boundary conditions and patient geometry for hundreds or even thousands of patients, such that estimates for FFR can reliably approximate measured FFR values. Thus, FFR values calculated by CFD techniques can be valuable for training the machine learning algorithms.
  • Referring now to the figures, FIG. 1 depicts a block diagram of an exemplary system and network for estimating patient-specific blood flow characteristics from vessel geometry and physiological information. Specifically, FIG. 1 depicts a plurality of physicians 102 and third party providers 104, any of whom may be connected to an electronic network 100, such as the Internet, through one or more computers, servers, and/or handheld mobile devices. Physicians 102 and/or third party providers 104 may create or otherwise obtain images of one or more patients' cardiac and/or vascular systems. The physicians 102 and/or third party providers 104 may also obtain any combination of patient-specific information, such as age, medical history, blood pressure, blood viscosity, etc. Physicians 102 and/or third party providers 104 may transmit the cardiac/vascular images and/or patient-specific information to server systems 106 over the electronic network 100. Server systems 106 may include storage devices for storing images and data received from physicians 102 and/or third party providers 104. Sever systems 106 may also include processing devices for processing images and data stored in the storage devices.
  • FIG. 2 is a block diagram of an exemplary method for estimating patient-specific blood flow characteristics from vessel geometry and physiological information, according to an exemplary embodiment of the present disclosure. The method of FIG. 2 may be performed by server systems 106, based on information received from physicians 102 and/or third party providers 104 over electronic network 100.
  • In one embodiment, the method of FIG. 2 may include a training method 202, for training one or more machine learning algorithms based on numerous patients' blood flow characteristic estimates, and a production method 204 for using the machine learning algorithm results to predict a particular patient's blood flow characteristics.
  • In one embodiment, training method 202 may be performed based on FFR estimates generating using CFD techniques for hundreds of patients. Training method 202 may involve acquiring, for each of a plurality of individuals, e.g., in digital format: (a) a patient-specific geometric model, (b) one or more measured or estimated physiological parameters, and (c) values of blood flow characteristics. Training method 202 may then involve, for one or more points in each patient's model, creating a feature vector of the patients' physiological parameters and associating the feature vector with the values of blood flow characteristics. For example, training method 202 may associate an estimated FFR with every point in a patient's geometric model. Training method 202 may then train a machine learning algorithm (e.g., using processing devices of server systems 106) to predict blood flow characteristics at each point of a geometric model, based on the feature vectors and blood flow characteristics. Training method 202 may then save the results of the machine learning algorithm, including feature weights, in a storage device of server systems 106. The stored feature weights may define the extent to which patient features or geometry are predictive of certain blood flow characteristics.
  • In one embodiment, the production method 204 may involve estimating FFR values for a particular patient, based on results of executing training method 202. In one embodiment, production method 204 may include acquiring, e.g. in digital format: (a) a patient-specific geometric model, and (b) one or more measured or estimated physiological parameters. For multiple points in the patient's geometric model, production method 204 may involve creating a feature vector of the physiological parameters used in the training mode. Production method 204 may then use saved results of the machine learning algorithm to produce estimates of the patient's blood flow characteristics for each point in the patient-specific geometric model. Finally, production method 204 may include saving the results of the machine learning algorithm, including predicted blood flow characteristics, to a storage device of server systems 106.
  • Described below are general and specific exemplary embodiments for implementing a training mode and a production mode of machine learning for predicting patient-specific blood flow characteristics, e.g. using server systems 106 based on images and data received from physicians 102 and/or third party providers 104 over electronic network 100.
  • General Embodiment
  • In a general embodiment, server systems 106 may perform a training mode based on images and data received from physicians 102 and/or third party providers 104 over electronic network 100. Specifically, for one or more patients, server systems 106 may acquire a digital representation (e.g., the memory or digital storage [e.g., hard drive, network drive] of a computational device such as a computer, laptop, DSP, server, etc.) of the following items: (a) a patient-specific model of the geometry for one or more of the patient's blood vessels; (b) a list of one or more measured or estimated physiological or phenotypic parameters of the patient; and/or (c) measurements, estimations or simulated values of all blood flow characteristic being targeted for prediction. In one embodiment, the patient-specific model of the geometry may be represented by a list of points in space (possibly with a list of neighbors for each point) in which the space can be mapped to spatial units between points (e.g., millimeters). In one embodiment, the list of one or more measured or estimated physiological or phenotypic parameters of the patient may include blood pressure, blood viscosity, patient age, patient gender, mass of the supplied tissue, etc. These patient-specific parameters may be global (e.g., blood pressure) or local (e.g., estimated density of the vessel wall at a particular location).
  • For every point in the patient-specific geometric model for which there is a measured, estimated or simulated value of the blood flow characteristic, server systems 106 may then create a feature vector for that point. The feature vector may be a numerical description of the patient-specific geometry at that point and estimates of physiological or phenotypic parameters of the patient. The feature vector may contain both global and local physiological or phenotypic parameters, where: for global parameters, all points have the same numerical value; and for local parameters, the value(s) may change at different points in the feature vector. Server systems 106 may then associate this feature vector with the measured, estimated or simulated value of the blood flow characteristic at this point.
  • Server systems 106 may then train a machine learning algorithm to predict the blood flow characteristics at the points from the feature vectors at the points. Examples of machine learning algorithms that can perform this task are support vector machines (SVMs), multi-layer perceptrons (MLPs), and multivariate regression (MVR) (e.g., weighted linear or logistic regression). Server systems 106 may then save the results of the machine learning algorithm (e.g., feature weights) to a digital representation (e.g., the memory or digital storage [e.g., hard drive, network drive] of a computational device such as a computer, laptop, DSP, server, etc.).
  • Also in a general embodiment, server systems 106 may perform a production mode based on images and data received from physicians 102 and/or third party providers 104 over electronic network 100. For a patient on whom a blood flow analysis is to be performed, server systems 106 may acquire a digital representation (e.g., the memory or digital storage [e.g., hard drive, network drive] of a computational device such as a computer, laptop, DSP, server, etc.) of (a) a patient-specific model of the geometry for one or more of the patient's blood vessels; and (b) a list of one or more estimates of physiological or phenotypic parameters of the patient. In one embodiment, the patient-specific model of the geometry for one or more of the patient's blood vessels may be represented as a list of points in space (possibly with a list of neighbors for each point) in which the space can be mapped to spatial units between points (e.g., millimeters). The list of one or more estimates of physiological or phenotypic parameters of the patient, may include blood pressure, blood viscosity, patient age, patient gender, the mass of the supplied tissue, etc. These parameters may be global (e.g., blood pressure) or local (e.g., estimated density of the vessel wall at a location). This list of parameters must be the same as the list used in the training mode.
  • For every point in the patient-specific geometric model, server systems 106 may create a feature vector that consists of a numerical description of the geometry and estimates of physiological or phenotypic parameters of the patient. Global physiological or phenotypic parameters can be used in the feature vector of all points and local physiological or phenotypic parameters can change in the feature vector of different points. These feature vectors may represent the same parameters used in the training mode. Server systems 106 may then use the saved results of the machine learning algorithm produced in the training mode (e.g., feature weights) to produce estimates of the blood flow characteristics at each point in the patient-specific geometric model. These estimates may be produced using the same machine learning algorithm technique used in the training mode (e.g., the SVM, MLP, MVR technique). Server systems 106 may also save the predicted blood flow characteristics for each point to a digital representation (e.g., the memory or digital storage [e.g., hard drive, network drive] of a computational device such as a computer, laptop, DSP, server, etc.).
  • Exemplary Embodiment
  • In one exemplary embodiment, server systems 106 may perform a training mode based on images and data received from physicians 102 and/or third party providers 104 over electronic network 100. Specifically, for one or more patients, server systems 106 may acquire a digital representation (e.g., the memory or digital storage [e.g., hard drive, network drive] of a computational device such as a computer, laptop, DSP, server, etc.) of (a) a patient-specific model of the geometry for the patient's ascending aorta and coronary artery tree; (b) a list of measured or estimated physiological or phenotypic parameters of the patient; and (c) measurements of the FFR when available.
  • In one embodiment, the patient-specific model of the geometry for the patient's ascending aorta and coronary artery tree may be represented as a list of points in space (possibly with a list of neighbors for each point) in which the space can be mapped to spatial units between points (e.g., millimeters). This model may be derived by performing a cardiac CT imaging study of the patient during the end diastole phase of the cardiac cycle. The resulting CT images may then be segmented manually or automatically to identify voxels belonging to the aorta and to the lumen of the coronary arteries. Once all relevant voxels are identified, the geometric model can be derived (e.g., using marching cubes).
  • In one embodiment, the list of measured or estimated physiological or phenotypic parameters of the patient may be obtained and may include: (i) systolic and diastolic blood pressures; (ii) heart rate; (iii) hematocrit level; (iv) patient age, gender, height, weight, general health status (presence or absence of diabetes, current medications); (v) lifestyle characteristics: smoker/non-smoker; and/or (vi) myocardial mass (may be derived by segmenting the myocardium obtained during the CT imaging study and then calculating the volume in the image; the mass is then computed using the computed volume and an estimated density (1.05 g/mL) of the myocardial mass.
  • In one embodiment, measurements of the FFR may be obtained when available. If the measured FFR value is not available at a given spatial location in the patient-specific geometric model, then a numerically computed value of the FFR at the point may be used. The numerically computed values may be obtained from a previous CFD simulation using the same geometric model and patient-specific boundary conditions derived from the physiological and phenotypic parameters listed above.
  • For every point in the patient-specific geometric model for which there is a measured, estimated or simulated value of the blood flow characteristics, server systems 106 may create a feature vector for that point that contains a numerical description of physiological or phenotypic parameters of the patient and a description of the local geometry. Specifically the feature vector may contain: (i) systolic and diastolic blood pressures; (ii) heart rate; (iii) blood properties including: plasma, red blood cells (erythrocytes), hematocrit, white blood cells (leukocytes) and platelets (thrombocytes), viscosity, yield stress; (iv) patient age, gender, height, weight, etc.; (v) diseases: presence or absence of diabetes, myocardial infarction, malignant and rheumatic conditions, peripheral vascular conditions, etc.; (vi) lifestyle characteristics: presence or absence of current medications/drugs, smoker/non-smoker; (vii) characteristics of the aortic geometry (Cross-sectional area of the aortic inlet and outlet, Surface area and volume of the aorta, Minimum, maximum, and average cross-sectional area, etc.); (viii) characteristics of the coronary branch geometry; and (ix) one or more feature sets.
  • In one embodiment, the characteristics of the coronary branch geometry may include: (i) volumes of the aorta upstream/downstream of the coronary branch point; (ii) cross-sectional area of the coronary/aorta bifurcation point, i.e., inlet to the coronary branch; (iii) total number of vessel bifurcations, and the number of upstream/downstream vessel bifurcations; (iv) average, minimum, and maximum upstream/downstream cross-sectional areas; (v) distances (along the vessel centerline) to the centerline point of minimum and maximum upstream/downstream cross-sectional areas; (vi) cross-sectional of and distance (along the vessel centerline) to the nearest upstream/downstream vessel bifurcation; (vii) cross-sectional area of and distance (along the vessel centerline) to the nearest coronary outlet and aortic inlet/outlet; (viii) cross-sectional areas and distances (along the vessel centerline) to the downstream coronary outlets with the smallest/largest cross-sectional areas; (ix) upstream/downstream volumes of the coronary vessels; and (x) upstream/downstream volume fractions of the coronary vessel with a cross-sectional area below a user-specified tolerance.
  • In one embodiment, a first feature set may define cross-sectional area features, such as a cross-sectional lumen area along the coronary centerline, a powered cross-sectional lumen area, a ratio of lumen cross-sectional area with respect to the main ostia (LM, RCA), a powered ratio of lumen cross-sectional area with respect to the main ostia, a degree of tapering in cross-sectional lumen area along the centerline, locations of stenotic lesions, lengths of stenotic lesions, location and number of lesions corresponding to 50%, 75%, 90% area reduction, distance from stenotic lesion to the main ostia, and/or irregularity (or circularity) of cross-sectional lumen boundary.
  • In one embodiment, the cross-sectional lumen area along the coronary centerline may be calculated by extracting a centerline from constructed geometry, smoothing the centerline if necessary, and computing cross-sectional area at each centerline point and map it to corresponding surface and volume mesh points. In one embodiment, the powered cross-sectional lumen area can be determined from various source of scaling laws. In one embodiment, the ratio of lumen cross-sectional area with respect to the main ostia (LM, RCA) can be calculated by measuring cross-sectional area at the LM ostium, normalizing cross-sectional area of the left coronary by LM ostium area, measuring cross-sectional area at the RCA ostium, and normalizing cross-sectional area of the right coronary by RCA ostium area. In one embodiment, the powered ratio of lumen cross-sectional area with respect to the main ostia can be determined from various source of scaling laws. In one embodiment, the degree of tapering in cross-sectional lumen area along the centerline can be calculated by sampling centerline points within a certain interval (e.g., twice the diameter of the vessel) and compute a slope of linearly-fitted cross-sectional area. In one embodiment, the location of stenotic lesions can be calculated by detecting minima of cross-sectional area curve, detecting locations where first derivative of area curve is zero and second derivative is positive, and computing distance (parametric arc length of centerline) from the main ostium. In one embodiment, the lengths of stenotic lesions can be calculated by computing the proximal and distal locations from the stenotic lesion, where cross-sectional area is recovered.
  • In one embodiment, another feature set may include intensity features that define, for example, intensity change along the centerline (slope of linearly-fitted intensity variation). In one embodiment, another feature set may include surface features that define, for example, 3D surface curvature of geometry (Gaussian, maximum, minimum, mean). In one embodiment, another feature set may include volume features that define, for example, a ratio of total coronary volume compared to myocardial volume. In one embodiment, another feature set may include centerline features that define, for example, curvature (bending) of coronary centerline, e.g., by computing Frenet curvature:
  • κ = p × p p 3 ,
  • where p is coordinate of centerline
  • or by computing an inverse of the radius of circumscribed circle along the centerline points. Curvature (bending) of coronary centerline may also be calculated based on tortuosity (non-planarity) of coronary centerline, e.g., by computing Frenet torsion:
  • τ = ( p × p ) · p ′′′ p × p 2 ,
  • where p is coordinate of centerline
  • In one embodiment, another feature set may include a SYNTAX scoring feature, including, for example, an existence of aorto ostial lesion, detection of a lesion located at the origin of the coronary from the aorta; and/or dominance (left or right).
  • In one embodiment, another feature set may include a simplified physics feature, e.g., including a fractional flow reserve value derived from Hagen-Poisseille flow assumption (Resistance˜Area−2). For example, in one embodiment, server systems 106 may compute the cross-sectional area of the origin (LM ostium or RCA ostium) of the coronary from the aorta (A0) with aortic pressure (P0); compute cross-sectional area of coronary vessel (Ai) at each sampled interval (Li); determine the amount of coronary flow in each segment of vessel using resistance boundary condition under hyperemic assumption (Qi); estimate resistance at each sampled location (Ri) based on:
  • R i = α i 8 μ L i π A i γ i + β i ,
  • where:
  • Nominal value μ=dynamic viscosiy of blood, αi=1.0, βi=0, γi=2.0 (Hagen-Poisseille).
  • Server systems 106 may estimate pressure drop (ΔPi) as ΔPi=QiRi and compute FFR at each sampled location as
  • FFR i = P 0 - k = 1 i Δ P k P 0 .
  • Locations of cross-sectional area minima or intervals smaller than vessel radius may be used for sampling locations. Server systems 106 may interpolate FFR along the centerline using FFRi, project FFR values to 3D surface mesh node, and vary αi, βi, γi and obtain new sets of FFR estimation as necessary for training, such as by using the feature sets defined above to perturb parameters where αi, βi can be a function of the diseased length, degree of stenosis and tapering ratio to account for tapered vessel; and Qi can be determined by summing distributed flow of each outlet on the basis of the same scaling law as the resistance boundary condition (outlet resistance ∝outlet area−1.35). However, a new scaling law and hyperemic assumption can be adopted, and this feature vector may be associated with the measurement or simulated value of the FFR at that point. Server systems 106 may also train a linear SVM to predict the blood flow characteristics at the points from the feature vectors at the points; and save the results of the SVM as a digital representation (e.g., the memory or digital storage [e.g., hard drive, network drive] of a computational device such as a computer, laptop, DSP, server, etc.).
  • In an exemplary production mode, servers systems 106 may, for a target patient, acquire in digital representation (e.g., the memory or digital storage (e.g., hard drive, network drive) of a computational device such as a computer, laptop, DSP, server, etc.): (a) a patient-specific model of the geometry for the patient's ascending aorta and coronary artery tree; and (b) a list of physiological and phenotypic parameters of the patient obtained during training mode. In one embodiment, the patient-specific model of the geometry for the patient's ascending aorta and coronary artery tree may be represented as a list of points in space (possibly with a list of neighbors for each point) in which the space can be mapped to spatial units between points (e.g., millimeters). This model may be derived by performing a cardiac CT imaging of the patient in the end diastole phase of the cardiac cycle. This image then may be segmented manually or automatically to identify voxels belonging to the aorta and the lumen of the coronary arteries. Once the voxels are identified, the geometric model can be derived (e.g., using marching cubes). The process for generating the patient-specific model of the geometry may be the same as in the training mode. For every point in the patient-specific geometric model, the server systems 106 may create a feature vector for that point that consists of a numerical description of the geometry at that point and estimates of physiological or phenotypic parameters of the patient. These features may be the same as the quantities used in the training mode. The server systems 106 may then use the saved results of the machine learning algorithm produced in the training mode (e.g., feature weights) to produce estimates of the FFR at each point in the patient-specific geometric model. These estimates may be produced using the same linear SVM technique used in the training mode. The server systems 106 may save the predicted FFR values for each point to a digital representation (e.g., the memory or digital storage [e.g., hard drive, network drive] of a computational device such as a computer, laptop, DSP, server, etc.).
  • In one embodiment, the above factors (i) thru (viii) (“Systolic and diastolic blood pressures” thru “Characteristics of the coronary branch geometry”) may be considered global features, which are applicable to all points within a given patient's geometric model. Also, items (ix) thru (xv) (“Feature Set I: Cross-sectional area feature” thru “Feature Set VII: Simplified Physics feature”) may be considered features that are local to specific points within a given patient's geometric model. In addition, features (i) thru (vi) may be considered variables within the function of boundary conditions, f(BCs), while features (vii) thru (xv) may be considered variables within the function of geometry, g(areaReductions), on that page. It will be appreciated that any combination of those features, modified by any desired weighting scheme, may be incorporated into a machine learning algorithm executed according to the disclosed embodiments.
  • In another embodiment, systems and methods are described to obtain estimates of physiologic metrics, such as ischemia, blood flow, or FFR from patient-specific anatomy and characteristics. The system may consist of a computer and software either on-site at a hospital or off-site that physicians load or transfer patient-specific data to. The anatomic data may consist of imaging data (ie CT) or measurements and anatomic representation already obtained from imaging data (quantitative angiography, vessel segmentations from third party software, vascular diameters, etc). Other patient characteristics may consist of heart rate, blood pressure, demographics such as age or sex, medication, disease states including diabetes and hypertension, prior MI, etc.
  • After relevant data is received by the system, it may be processed by software automation, the physician using the system, a third-party technician or analyst using the system, or any combination. The data may be processed using algorithms relating the patient's anatomy and characteristics to functional estimates of ischemia and blood flow. The algorithms may employ empirically derived models, machine learning, or analytical models relating blood flow to anatomy. Estimates of ischemia (blood flow, FFR, etc) may be generated for a specific location in a vessel, as an overall estimate for the vessel, or for an entire system of vessels such as the coronary arteries. A numeric output, such as an FFR value, may be generated or simple positive/negative/inconclusive indications based on clinical metrics may be provided (ie FFR> or <0.80). Along with the output, a confidence may be provided. Results of the analysis may be displayed or stored in a variety of media, including images, renderings, tables of values, or reports and may be transferred back to the physician through the system or through other electronic or physical delivery methods.
  • In one embodiment, the algorithm to estimate FFR from patient anatomy consists of deriving an analytical model based on fundamentals of physiology and physics, for example analytical fluid dynamics equations and morphometry scaling laws. Information about the following coronary anatomy, including but not limited to the following features derived from imaging data (ie CT), serves as an input:
  • Vessel sizes
  • Vessel size at ostium
  • Vessel size at distal branches
  • Reference and minimum vessel size at plaque
  • Distance from ostium to plaque
  • Length of plaque and length of minimum vessel size
  • Myocardial volume
  • Branches proximal/distal to measurement location
  • Branches proximal/distal to plaque
  • Measurement location
  • Using some or all of the information above, a network of flow resistance may be created. Pressure drop may be estimated by relating the amount of blood flow to the resistance to blood flow using any of a variety of analytical models, such as Poiseuille's equation, energy loss models, etc. As an example embodiment:

  • FFR=(P−ΔP)/P where P is the aortic pressure and ΔP is the change in pressure from the aorta to the location of interest.

  • ΔP=QR, where Q is flow rate, and R is resistance
  • The flow rate may be estimated by morphometry relations, such as Q ∝Mk where M is the myocardial volume and k is an exponent, often approximately 0.75. Individual vessel flow rates may scale based on the morphometry relationship of Q∝Dk where D is the diameter of the vessel and k is an exponent, often between 2 and 3.
  • In an example embodiment, the resistance through a vessel may be estimated by Poiseuille's equation:

  • R∝μL/D 4 where μ is viscosity, L is length, and D is diameter
  • Downstream, or microvascular resistances may be estimated through morphometric tree generation or other methods described in Ser. Nos. 13/014,809 and 08/157,742. FFR can be estimated by relating all the resistance and flow estimates in a network representing the distribution of vessels in the coronary circulation, and pressure can be solved.
  • In another embodiment, regression or machine learning may be employed to train the algorithm using the features previously mentioned, formulations of resistances and flows, and additional anatomic and patient characteristics, including but not limited to:
  • Age, sex, and other demographics
  • Heart rate, blood pressure, and other physiologic measures
  • Disease state, such as hypertension, diabetes, previous cardiac events
  • Vessel dominance
  • Plaque type
  • Plaque shape
  • Prior simulation results, such as full 3D simulations of FFR
  • A library or database of anatomic and patient characteristics along with FFR, ischemia test results, previous simulation results, imaging data, or other metrics may be compiled. For every point of interest where an FFR estimation is required, a set of features may be generated. A regression or machine learning technique, such as linear regression or decision trees, may be used to define which features have the largest impact on estimating FFR and to create an algorithm that weights the various features. Example embodiments may estimate FFR numerically, classify a vessel as ischemia positive or negative, or classify a patient as ischemia positive or negative.
  • Once an algorithm is created, it may be executed on new data provided by the physician to the system. As previously described, a number of methods may be used to generate the anatomic information required, and once obtained, the features defined, algorithm performed, and results reported. Along with numerical or classification results, a confidence from the machine learning algorithm may be provided. One example embodiment is to report that a particular vessel in a patient has a specific percent confidence of being positive or negative for ischemia, ie Left anterior descending artery is positive with 85% confidence. Over time, the algorithm may be refined or updated as additional patient data is added to the library or database.
  • One additional embodiment is to derive any of the previously mentioned parameters, physiologic, or physical estimations empirically. Coupled with machine learning or analytic techniques, empirical studies of flow and pressure across various geometries may be utilized to inform the algorithms.
  • Other embodiments of the invention will be apparent to those skilled in the art from consideration of the specification and practice of the invention disclosed herein. It is intended that the specification and examples be considered as exemplary only, with a true scope and spirit of the invention being indicated by the following claims.

Claims (28)

1-31. (canceled)
32. A method for determining fractional flow reserve (FFR) for a plaque of interest for a patient, comprising:
receiving a medical image of the patient including the plaque of interest;
detecting image regions corresponding to the plaque of interest and a coronary artery tree of the patient; and
determining an FFR value associated with the plaque of interest using a trained machine learning algorithm applied directly to the detected image regions.
33. The method of claim 32, wherein detecting image regions corresponding to the plaque of interest and a coronary tree of the patient comprises:
detecting image regions corresponding to the plaque of interest, coronary ostia, coronary vessels, and coronary branching.
34. The method of claim 32, wherein detecting image regions corresponding to the plaque of interest and a coronary tree of the patient comprises:
detecting the image regions in one or more feature vector spaces using a respective trained machine learning algorithm for each of the feature vector spaces.
35. The method of claim 34, wherein the one or more feature vector spaces comprises a position parameter space, and a position-curvature parameter space.
36. The method of claim 34, wherein the respective trained machine learning algorithm for each of the feature vector spaces comprises a machine learning algorithm trained that inputs parameters, and for each parameter outputs a prediction for an image region in the respective parameter space.
37. The method of claim 34, wherein the respective trained machine learning algorithm for each of the feature vector spaces comprises a discriminative machine learning algorithm that inputs parameters, and for each parameter outputs a confidence for the image region corresponding to the prediction.
38. The method of claim 34, wherein the respective machine learning algorithm for each of the feature vector spaces is a machine learning algorithm trained using one of a support vector machine (SVM), multi-layer perceptron (MLPs), and multivariate regression (MVR).
39. The method of claim 32, wherein the trained machine learning algorithm is a machine learning algorithm with a plurality of layers and a final layer calculates a plaque specific FFR value.
40. The method of claim 39, wherein the trained machine learning algorithm is trained by tuning weights for each layer other than the final layer using a first set of training images without corresponding FFR values and then refining the weights for each layer including the final layer based on a second set of training images with corresponding FFR values.
41. An apparatus for determining fractional flow reserve (FFR) for a plaque of interest for a patient, comprising:
means for receiving a medical image of the patient including the plaque of interest;
means for detecting image regions corresponding to the plaque of interest and a coronary tree of the patient; and
means for determining an FFR value for the plaque of interest using a trained machine learning algorithm applied directly to the detected image regions.
42. The apparatus of claim 41, wherein the means for detecting image regions corresponding to the plaque of interest and a coronary tree of the patient comprises:
means for detecting image regions corresponding to the plaque of interest, coronary ostia, coronary vessels, and coronary branching.
43. The apparatus of claim 41, wherein the means for detecting image regions corresponding to the plaque of interest and a coronary tree of the patient comprises:
means for detecting the image regions in a series of feature vector spaces using a respective trained machine learning algorithm for each of the feature vector spaces.
44. The apparatus of claim 43, wherein the series of feature vector spaces comprises a position parameter space, a position-curvature parameter space, and a position-curvature-scale parameter space.
45. The apparatus of claim 43, wherein the respective trained machine learning algorithm for each of the feature vector spaces comprises a machine learning algorithm trained that inputs hypotheses in the respective parameter space and for each hypothesis, outputs a prediction for an image region in the respective parameter space.
46. The apparatus of claim 43, wherein the respective trained machine learning algorithm for each of the feature vector spaces comprises a discriminative machine learning algorithm that inputs hypotheses in the respective parameters space, and for each hypothesis outputs a confidence for the image region corresponding to the hypothesis.
47. The apparatus of claim 43, wherein the respective machine learning algorithm for each of the feature vector spaces is a machine learning algorithm trained using one of a convolutional neural network (CNN), a stacked restricted Boltzmann machine (RBM), or a stacked auto-encoder (AE).
48. The apparatus of claim 41, wherein the trained machine learning algorithm is a machine learning algorithm with a plurality of layers and a final layer calculates a plaque specific FFR value.
49. The apparatus of claim 48, wherein the trained machine learning algorithm is trained by tuning weights for each layer other than the final layer using a first set of training images without corresponding FFR values and then refining the weights for each layer including the final layer based on a second set of training images with corresponding FFR values.
50. A non-transitory computer readable medium storing computer program instructions for determining fractional flow reserve (FFR) for a plaque of interest for a patient, the computer program instructions when executed by a processor cause the processor to perform operations comprising:
receiving a medical image of the patient including the plaque of interest;
detecting image regions corresponding to the plaque of interest and a coronary tree of the patient; and
determining an FFR value for the plaque of interest using a trained machine learning algorithm applied directly to the detected image regions.
51. The non-transitory computer readable medium of claim 50, wherein detecting image regions corresponding to the plaque of interest and a coronary tree of the patient comprises:
detecting image regions corresponding to the plaque of interest, coronary ostia, coronary vessels, and coronary branching.
52. The non-transitory computer readable medium of claim 50, wherein detecting image regions corresponding to the plaque of interest and a coronary tree of the patient comprises:
detecting the image regions in a series of feature vector spaces using a respective trained machine learning algorithm for each of the feature vector spaces.
53. The non-transitory computer readable medium of claim 52, wherein the series of feature vector spaces comprises a position parameter space, a position-curvature parameter space, and a position-curvature-scale parameter space.
54. The non-transitory computer readable medium of claim 52, wherein the respective trained machine learning algorithm for each of the feature vector spaces comprises a machine learning algorithm trained that inputs hypotheses in the respective parameter space and for each hypothesis, outputs a prediction for an image region in the respective parameter space.
55. The non-transitory computer readable medium of claim 52, wherein the respective trained machine learning algorithm for each of the feature vector spaces comprises a discriminative machine learning algorithm that inputs hypotheses in the respective parameters space, and for each hypothesis outputs a confidence for the image region corresponding to the hypothesis.
56. The non-transitory computer readable medium of claim 52, wherein the respective machine learning algorithm for each of the feature vector spaces is a machine learning algorithm trained using one of a convolutional neural network (CNN), a stacked restricted Boltzmann machine (RBM), or a stacked auto-encoder (AE).
57. The non-transitory computer readable medium of claim 50, wherein the trained machine learning algorithm is a machine learning algorithm with a plurality of layers and a final layer calculates a plaque specific FFR value.
58. The non-transitory computer readable medium of claim 57, wherein the trained machine learning algorithm is trained by tuning weights for each layer other than the final layer using a first set of training images without corresponding FFR values and then refining the weights for each layer including the final layer based on a second set of training images with corresponding FFR values.
US15/200,160 2012-09-12 2016-07-01 Systems and methods for estimating ischemia and blood flow characteristics from vessel geometry and physiology Abandoned US20160310018A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US15/200,160 US20160310018A1 (en) 2012-09-12 2016-07-01 Systems and methods for estimating ischemia and blood flow characteristics from vessel geometry and physiology

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201261700213P 2012-09-12 2012-09-12
US201361793673P 2013-03-15 2013-03-15
US13/895,871 US10433740B2 (en) 2012-09-12 2013-05-16 Systems and methods for estimating ischemia and blood flow characteristics from vessel geometry and physiology
US15/200,160 US20160310018A1 (en) 2012-09-12 2016-07-01 Systems and methods for estimating ischemia and blood flow characteristics from vessel geometry and physiology

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US13/895,871 Continuation US10433740B2 (en) 2012-09-12 2013-05-16 Systems and methods for estimating ischemia and blood flow characteristics from vessel geometry and physiology

Publications (1)

Publication Number Publication Date
US20160310018A1 true US20160310018A1 (en) 2016-10-27

Family

ID=50234016

Family Applications (13)

Application Number Title Priority Date Filing Date
US13/895,871 Active US10433740B2 (en) 2012-09-12 2013-05-16 Systems and methods for estimating ischemia and blood flow characteristics from vessel geometry and physiology
US14/716,046 Abandoned US20150245775A1 (en) 2012-09-12 2015-05-19 Systems and methods for estimating ischemia and blood flow characteristics from vessel geometry and physiology
US15/200,402 Active US9974453B2 (en) 2012-09-12 2016-07-01 Systems and methods for estimating ischemia and blood flow characteristics from vessel geometry and physiology
US15/200,318 Active US10010255B2 (en) 2012-09-12 2016-07-01 Systems and methods for estimating ischemia and blood flow characteristics from vessel geometry and physiology
US15/200,160 Abandoned US20160310018A1 (en) 2012-09-12 2016-07-01 Systems and methods for estimating ischemia and blood flow characteristics from vessel geometry and physiology
US15/205,583 Abandoned US20160317114A1 (en) 2012-09-12 2016-07-08 Systems and methods for estimating ischemia and blood flow characteristics from vessel geometry and physiology
US15/205,623 Abandoned US20160321417A1 (en) 2012-09-12 2016-07-08 Systems and methods for estimating ischemia and blood flow characteristics from vessel geometry and physiology
US15/205,536 Abandoned US20160317046A1 (en) 2012-09-12 2016-07-08 Systems and methods for estimating ischemia and blood flow characteristics from vessel geometry and physiology
US15/624,424 Active 2034-03-12 US10561324B2 (en) 2012-09-12 2017-06-15 Systems and methods of image processing to determine flow characteristics
US15/961,449 Active 2034-02-09 US10966619B2 (en) 2012-09-12 2018-04-24 Systems and methods for estimating ischemia and blood flow characteristics from vessel geometry and physiology
US16/555,145 Active 2034-01-10 US11399729B2 (en) 2012-09-12 2019-08-29 Systems and methods for estimating ischemia and blood flow characteristics from vessel geometry and physiology
US16/944,772 Active US11013425B2 (en) 2012-09-12 2020-07-31 Systems and methods for analyzing and processing digital images to estimate vessel characteristics
US17/808,596 Pending US20220322953A1 (en) 2012-09-12 2022-06-24 Systems and methods for processing electronic images to evaluate medical images

Family Applications Before (4)

Application Number Title Priority Date Filing Date
US13/895,871 Active US10433740B2 (en) 2012-09-12 2013-05-16 Systems and methods for estimating ischemia and blood flow characteristics from vessel geometry and physiology
US14/716,046 Abandoned US20150245775A1 (en) 2012-09-12 2015-05-19 Systems and methods for estimating ischemia and blood flow characteristics from vessel geometry and physiology
US15/200,402 Active US9974453B2 (en) 2012-09-12 2016-07-01 Systems and methods for estimating ischemia and blood flow characteristics from vessel geometry and physiology
US15/200,318 Active US10010255B2 (en) 2012-09-12 2016-07-01 Systems and methods for estimating ischemia and blood flow characteristics from vessel geometry and physiology

Family Applications After (8)

Application Number Title Priority Date Filing Date
US15/205,583 Abandoned US20160317114A1 (en) 2012-09-12 2016-07-08 Systems and methods for estimating ischemia and blood flow characteristics from vessel geometry and physiology
US15/205,623 Abandoned US20160321417A1 (en) 2012-09-12 2016-07-08 Systems and methods for estimating ischemia and blood flow characteristics from vessel geometry and physiology
US15/205,536 Abandoned US20160317046A1 (en) 2012-09-12 2016-07-08 Systems and methods for estimating ischemia and blood flow characteristics from vessel geometry and physiology
US15/624,424 Active 2034-03-12 US10561324B2 (en) 2012-09-12 2017-06-15 Systems and methods of image processing to determine flow characteristics
US15/961,449 Active 2034-02-09 US10966619B2 (en) 2012-09-12 2018-04-24 Systems and methods for estimating ischemia and blood flow characteristics from vessel geometry and physiology
US16/555,145 Active 2034-01-10 US11399729B2 (en) 2012-09-12 2019-08-29 Systems and methods for estimating ischemia and blood flow characteristics from vessel geometry and physiology
US16/944,772 Active US11013425B2 (en) 2012-09-12 2020-07-31 Systems and methods for analyzing and processing digital images to estimate vessel characteristics
US17/808,596 Pending US20220322953A1 (en) 2012-09-12 2022-06-24 Systems and methods for processing electronic images to evaluate medical images

Country Status (1)

Country Link
US (13) US10433740B2 (en)

Cited By (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9953272B2 (en) 2013-10-23 2018-04-24 Stenomics, Inc. Machine learning system for assessing heart valves and surrounding cardiovascular tracts
EP3404667A1 (en) * 2017-05-19 2018-11-21 Siemens Healthcare GmbH Learning based methods for personalized assessment, long-term prediction and management of atherosclerosis
US20190038239A1 (en) * 2017-08-03 2019-02-07 Siemens Healthcare Gmbh Ascertaining a function parameter relating to a local tissue function for plurality of tissue regions
US20190130074A1 (en) * 2017-10-30 2019-05-02 Siemens Healthcare Gmbh Machine-learnt prediction of uncertainty or sensitivity for hemodynamic quantification in medical imaging
US20190172197A1 (en) * 2015-08-14 2019-06-06 Elucid Bioimaging Inc. Methods and systems for utilizing quantitative imaging
US10483006B2 (en) 2017-05-19 2019-11-19 Siemens Healthcare Gmbh Learning based methods for personalized assessment, long-term prediction and management of atherosclerosis
US10497476B2 (en) 2013-05-10 2019-12-03 Stenomics, Inc. Modeling and simulation system for optimizing prosthetic heart valve treatment
US10762637B2 (en) * 2017-10-27 2020-09-01 Siemens Healthcare Gmbh Vascular segmentation using fully convolutional and recurrent neural networks
US11071501B2 (en) 2015-08-14 2021-07-27 Elucid Bioiwaging Inc. Quantitative imaging for determining time to adverse event (TTE)
US11087460B2 (en) 2015-08-14 2021-08-10 Elucid Bioimaging Inc. Methods and systems for training and validating quantitative imaging biomarkers
US11113812B2 (en) 2015-08-14 2021-09-07 Elucid Bioimaging Inc. Quantitative imaging for detecting vulnerable plaque
US11120312B2 (en) 2015-08-14 2021-09-14 Elucid Bioimaging Inc. Quantitative imaging for cancer subtype
US20210390689A1 (en) * 2015-08-14 2021-12-16 Elucid Bioimaging Inc Non-invasive quantitative imaging biomarkers of atherosclerotic plaque biology
US11508063B2 (en) 2019-08-05 2022-11-22 Elucid Bioimaging Inc. Non-invasive measurement of fibrous cap thickness
US11869186B2 (en) 2021-06-10 2024-01-09 Elucid Bioimaging Inc. Non-invasive determination of likely response to combination therapies for cardiovascular disease
US11871995B2 (en) 2017-12-18 2024-01-16 Hemolens Diagnostics Sp. Z O.O. Patient-specific modeling of hemodynamic parameters in coronary arteries
US11887713B2 (en) 2021-06-10 2024-01-30 Elucid Bioimaging Inc. Non-invasive determination of likely response to anti-diabetic therapies for cardiovascular disease
US11887734B2 (en) 2021-06-10 2024-01-30 Elucid Bioimaging Inc. Systems and methods for clinical decision support for lipid-lowering therapies for cardiovascular disease
US11887701B2 (en) 2021-06-10 2024-01-30 Elucid Bioimaging Inc. Non-invasive determination of likely response to anti-inflammatory therapies for cardiovascular disease
US12008751B2 (en) 2015-08-14 2024-06-11 Elucid Bioimaging Inc. Quantitative imaging for detecting histopathologically defined plaque fissure non-invasively
US12026868B2 (en) 2015-08-14 2024-07-02 Elucid Bioimaging Inc. Quantitative imaging for detecting histopathologically defined plaque erosion non-invasively
US12125572B2 (en) 2023-08-09 2024-10-22 Elucid Bioimaging Inc. Determining likely response to anti-inflammatory and pro-resolving therapies for cardiovascular disease non-invasively

Families Citing this family (92)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9521961B2 (en) 2007-11-26 2016-12-20 C. R. Bard, Inc. Systems and methods for guiding a medical instrument
US8781555B2 (en) 2007-11-26 2014-07-15 C. R. Bard, Inc. System for placement of a catheter including a signal-generating stylet
ES2651898T3 (en) 2007-11-26 2018-01-30 C.R. Bard Inc. Integrated system for intravascular catheter placement
US8200466B2 (en) 2008-07-21 2012-06-12 The Board Of Trustees Of The Leland Stanford Junior University Method for tuning patient-specific cardiovascular simulations
US9405886B2 (en) 2009-03-17 2016-08-02 The Board Of Trustees Of The Leland Stanford Junior University Method for determining cardiovascular information
US9532724B2 (en) 2009-06-12 2017-01-03 Bard Access Systems, Inc. Apparatus and method for catheter navigation using endovascular energy mapping
EP2912999B1 (en) 2010-05-28 2022-06-29 C. R. Bard, Inc. Apparatus for use with needle insertion guidance system
US8315812B2 (en) 2010-08-12 2012-11-20 Heartflow, Inc. Method and system for patient-specific modeling of blood flow
US10398386B2 (en) * 2012-09-12 2019-09-03 Heartflow, Inc. Systems and methods for estimating blood flow characteristics from vessel geometry and physiology
US10433740B2 (en) 2012-09-12 2019-10-08 Heartflow, Inc. Systems and methods for estimating ischemia and blood flow characteristics from vessel geometry and physiology
US9805463B2 (en) * 2013-08-27 2017-10-31 Heartflow, Inc. Systems and methods for predicting location, onset, and/or change of coronary lesions
US9700219B2 (en) * 2013-10-17 2017-07-11 Siemens Healthcare Gmbh Method and system for machine learning based assessment of fractional flow reserve
US9730643B2 (en) 2013-10-17 2017-08-15 Siemens Healthcare Gmbh Method and system for anatomical object detection using marginal space deep neural networks
US9668699B2 (en) 2013-10-17 2017-06-06 Siemens Healthcare Gmbh Method and system for anatomical object detection using marginal space deep neural networks
US9501622B2 (en) 2014-03-05 2016-11-22 Heartflow, Inc. Methods and systems for predicting sensitivity of blood flow calculations to changes in anatomical geometry
US9390232B2 (en) * 2014-03-24 2016-07-12 Heartflow, Inc. Systems and methods for modeling changes in patient-specific blood vessel geometry and boundary conditions
US9785746B2 (en) 2014-03-31 2017-10-10 Heartflow, Inc. Systems and methods for determining blood flow characteristics using flow ratio
WO2016001017A1 (en) 2014-06-30 2016-01-07 Koninklijke Philips N.V. Apparatus for determining a fractional flow reserve value
US9390224B2 (en) 2014-08-29 2016-07-12 Heartflow, Inc. Systems and methods for automatically determining myocardial bridging and patient impact
US10628940B2 (en) * 2014-09-08 2020-04-21 The Cleveland Clinic Foundation Automated analysis of angiographic images
US9336354B1 (en) 2014-11-04 2016-05-10 Heartflow, Inc. Systems and methods for simulation of hemodialysis access and optimization
US10080872B2 (en) 2014-11-04 2018-09-25 Abbott Cardiovascular Systems Inc. System and method for FFR guidewire recovery
US9594876B2 (en) * 2014-11-04 2017-03-14 Heartflow, Inc. Systems and methods for simulation of occluded arteries and optimization of occlusion-based treatments
US9349178B1 (en) 2014-11-24 2016-05-24 Siemens Aktiengesellschaft Synthetic data-driven hemodynamic determination in medical imaging
EP4418206A2 (en) * 2014-11-14 2024-08-21 Siemens Healthineers AG Method and system for purely geometric machine learning based fractional flow reserve
WO2016075331A2 (en) * 2014-11-14 2016-05-19 Siemens Healthcare Gmbh Method and system for purely geometric machine learning based fractional flow reserve
US10595790B2 (en) 2014-12-16 2020-03-24 Siemens Healthcare Gmbh Method and system for personalized non-invasive hemodynamic assessment of renal artery stenosis from medical images
US20160203289A1 (en) 2015-01-14 2016-07-14 Heartflow, Inc. Systems and methods for embolism prediction using embolus source and destination probabilities
US20160224753A1 (en) * 2015-02-02 2016-08-04 Heartflow, Inc. Systems and methods for diagnosis, risk assessment, and/or virtual treatment assessment of visceral ischemia
AU2016242999B2 (en) * 2015-04-02 2018-11-22 Heartflow, Inc. Systems and methods for predicting perfusion deficits from physiological, anatomical, and patient characteristics
CN107615335A (en) * 2015-05-12 2018-01-19 新加坡保健服务集团有限公司 medical image processing method and system
US11147505B1 (en) * 2015-06-01 2021-10-19 Verily Life Sciences Llc Methods, systems and devices for identifying an abnormal sleep condition
US10872698B2 (en) * 2015-07-27 2020-12-22 Siemens Healthcare Gmbh Method and system for enhancing medical image-based blood flow computations using physiological measurements
TWI545516B (en) * 2015-09-16 2016-08-11 國立交通大學 System and method for blood pressure measurement, a computer program product using the method, and a computer-readable recording medium thereof
US10492754B2 (en) 2015-11-20 2019-12-03 International Business Machines Corporation Real-time cloud-based virtual fractional flow reserve estimation
US11191490B2 (en) * 2015-12-02 2021-12-07 Siemens Healthcare Gmbh Personalized assessment of patients with acute coronary syndrome
CN105326486B (en) 2015-12-08 2017-08-25 博动医学影像科技(上海)有限公司 Vascular pressure difference and the computational methods and system of blood flow reserve fraction
US10758125B2 (en) 2016-04-29 2020-09-01 Siemens Healthcare Gmbh Enhanced personalized evaluation of coronary artery disease using an integration of multiple medical imaging techniques
US20170322684A1 (en) * 2016-05-03 2017-11-09 Siemens Healthcare Gmbh Automation Of Clinical Scoring For Decision Support
CN106073894B (en) * 2016-05-31 2017-08-08 博动医学影像科技(上海)有限公司 Vascular pressure drop numerical value and the appraisal procedure and system of blood flow reserve fraction based on implantation virtual bracket
US11020563B2 (en) 2016-07-14 2021-06-01 C. R. Bard, Inc. Automated catheter-to-vessel size comparison tool and related methods
CN109688908B (en) * 2016-09-16 2023-01-03 皇家飞利浦有限公司 Apparatus and method for determining fractional flow reserve
DE102016222102A1 (en) * 2016-11-10 2018-05-17 Siemens Healthcare Gmbh Treatment planning for a stenosis in a vascular segment using a virtual hemodynamic analysis
EP3270355B1 (en) * 2017-01-27 2019-07-31 Siemens Healthcare GmbH Determining a complexity value of a stenosis or a section of a vessel
US10176896B2 (en) * 2017-03-01 2019-01-08 Siemens Healthcare Gmbh Coronary computed tomography clinical decision support system
WO2018185040A1 (en) * 2017-04-06 2018-10-11 Koninklijke Philips N.V. Standardized coronary artery disease metric
EP3270308B9 (en) * 2017-06-14 2022-05-18 Siemens Healthcare GmbH Method for providing a secondary parameter, decision support system, computer-readable medium and computer program product
US10373315B2 (en) 2017-06-19 2019-08-06 Viz.ai Inc. Method and system for computer-aided triage
US11633118B2 (en) * 2017-06-30 2023-04-25 Koninklijke Philips N.V. Machine learning spectral FFR-CT
US10679384B2 (en) 2017-09-29 2020-06-09 General Electric Company Systems and methods for deep learning-based image reconstruction
EP3488774A1 (en) * 2017-11-23 2019-05-29 Koninklijke Philips N.V. Measurement guidance for coronary flow estimation from bernoulli´s principle
CN108511075B (en) * 2018-03-29 2022-10-25 杭州脉流科技有限公司 Method and system for non-invasively acquiring fractional flow reserve
CN108777174B (en) * 2018-06-20 2021-11-05 博动医学影像科技(上海)有限公司 Method and device for acquiring blood vessel pressure difference based on myocardial infarction history information
CN108784676B (en) * 2018-06-20 2021-11-09 博动医学影像科技(上海)有限公司 Method and device for acquiring pressure difference based on age information
CN108717874B (en) * 2018-06-20 2021-11-05 博动医学影像科技(上海)有限公司 Method and device for obtaining blood vessel pressure value based on specific physiological parameters
CN108742586B (en) * 2018-06-20 2021-04-02 博动医学影像科技(上海)有限公司 Method and device for acquiring blood flow characteristic value based on diabetes history information
CN109065170B (en) * 2018-06-20 2021-11-19 博动医学影像科技(上海)有限公司 Method and device for acquiring blood vessel pressure difference
CN109033219B (en) * 2018-06-29 2022-03-11 北京奇虎科技有限公司 Point of interest (POI) classification method and device
WO2020081373A1 (en) 2018-10-16 2020-04-23 Bard Access Systems, Inc. Safety-equipped connection systems and methods thereof for establishing electrical connections
CN111227821B (en) * 2018-11-28 2022-02-11 苏州润迈德医疗科技有限公司 Microcirculation resistance index calculation method based on myocardial blood flow and CT (computed tomography) images
US10964017B2 (en) 2018-11-15 2021-03-30 General Electric Company Deep learning for arterial analysis and assessment
US11227418B2 (en) 2018-12-28 2022-01-18 General Electric Company Systems and methods for deep learning-based image reconstruction
US20220093267A1 (en) * 2019-01-22 2022-03-24 Arizona Board Of Regents On Behalf Of The University Of Arizona Noninvasive real-time patient-specific assessment of stroke severity
US10813612B2 (en) 2019-01-25 2020-10-27 Cleerly, Inc. Systems and method of characterizing high risk plaques
WO2020167631A1 (en) * 2019-02-11 2020-08-20 University Of Louisville Research Foundation, Inc. System and method for determining a blood flow characteristic
CN111476791B (en) * 2019-05-21 2024-02-09 科亚医疗科技股份有限公司 Image processing method, image processing apparatus, and non-transitory computer readable medium
CN110279404B (en) * 2019-06-17 2020-07-28 清华大学 Pulse wave acquisition device and method
US11462318B2 (en) 2019-06-27 2022-10-04 Viz.ai Inc. Method and system for computer-aided triage of stroke
US20210000356A1 (en) * 2019-07-02 2021-01-07 Tata Consultancy Services Limited Method and system for screening and monitoring of cardiac diseases
CN110522465B (en) 2019-07-22 2024-09-06 通用电气精准医疗有限责任公司 Method and system for estimating hemodynamic parameters based on image data
EP4004946A4 (en) * 2019-07-30 2023-08-02 Viz.ai, Inc. Method and system for computer-aided triage of stroke
US11759166B2 (en) 2019-09-20 2023-09-19 Bard Access Systems, Inc. Automatic vessel detection tools and methods
US11416360B2 (en) * 2019-10-09 2022-08-16 Fujifilm Medical Systems U.S.A., Inc. Systems and methods for detecting errors in artificial intelligence engines
US12109060B2 (en) 2019-10-10 2024-10-08 Medstar Health, Inc. Noninvasive assessment of microvascular dysfunction
US11969280B2 (en) 2020-01-07 2024-04-30 Cleerly, Inc. Systems, methods, and devices for medical image analysis, diagnosis, risk stratification, decision making and/or disease tracking
US11501436B2 (en) 2020-01-07 2022-11-15 Cleerly, Inc. Systems, methods, and devices for medical image analysis, diagnosis, risk stratification, decision making and/or disease tracking
US20220392065A1 (en) 2020-01-07 2022-12-08 Cleerly, Inc. Systems, methods, and devices for medical image analysis, diagnosis, risk stratification, decision making and/or disease tracking
US20230103319A1 (en) * 2020-01-31 2023-04-06 See-Mode Technologies Pte Ltd Methods and systems for risk assessment of ischemic cerebrovascular events
KR102190431B1 (en) 2020-03-18 2020-12-11 연세대학교 산학협력단 Method and Apparatus for Diagnosing Vascular Disease
WO2021248046A1 (en) * 2020-06-04 2021-12-09 The Regents Of The University Of California Mathematical modeling of blood flow to evaluate hemodynamic significance of peripheral vascular legions
WO2021257906A1 (en) * 2020-06-17 2021-12-23 Northwestern University Maskless 2d/3d artificial subtraction angiography
US11877810B2 (en) 2020-07-21 2024-01-23 Bard Access Systems, Inc. System, method and apparatus for magnetic tracking of ultrasound probe and generation of 3D visualization thereof
CN215839160U (en) 2020-09-03 2022-02-18 巴德阿克塞斯系统股份有限公司 Portable ultrasound probe and system
CN114145772A (en) 2020-09-08 2022-03-08 巴德阿克塞斯系统股份有限公司 Dynamically adjusted ultrasound imaging system and method thereof
CN114246614A (en) 2020-09-25 2022-03-29 巴德阿克塞斯系统股份有限公司 Ultrasound imaging system and minimum catheter length tool
US12048491B2 (en) 2020-12-01 2024-07-30 Bard Access Systems, Inc. Ultrasound probe with target tracking capability
CN113100737B (en) * 2021-04-06 2023-10-27 复旦大学附属中山医院 Ischemia myocardial load quantitative evaluation system based on coronary artery CTA
US11694807B2 (en) 2021-06-17 2023-07-04 Viz.ai Inc. Method and system for computer-aided decision guidance
US11980492B2 (en) 2021-11-05 2024-05-14 GE Precision Healthcare LLC System and method for deep-learning based estimation of coronary artery pressure drop
US20230289963A1 (en) 2022-03-10 2023-09-14 Cleerly, Inc. Systems, devices, and methods for non-invasive image-based plaque analysis and risk determination
US12102481B2 (en) 2022-06-03 2024-10-01 Bard Access Systems, Inc. Ultrasound probe with smart accessory
EP4428871A1 (en) 2023-03-09 2024-09-11 Hemolens Diagnostics Spólka Z Ograniczona Odpowiedzialnoscia A method of training an artificial deep neural network for estimation of hemodynamic parameter, a method of estimation of hemodynamic parameter, computer program products and computer systems

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6377832B1 (en) * 1998-03-20 2002-04-23 Georgia Tech Research Corporation System and method for analyzing a medical image
US20050005987A1 (en) * 2003-07-12 2005-01-13 Hayes Frank F. Method and apparatus for forming flared tube ends
US20050059876A1 (en) * 2003-06-25 2005-03-17 Sriram Krishnan Systems and methods for providing automated regional myocardial assessment for cardiac imaging
US20080292049A1 (en) * 2007-05-21 2008-11-27 Estelle Camus Device for obtaining perfusion images
US20090103794A1 (en) * 2007-10-19 2009-04-23 Boston Scientific Scimed, Inc. Display of classifier output and confidence measure in an image
US20120053918A1 (en) * 2010-08-12 2012-03-01 Heartflow, Inc. Method and system for patient-specific modeling of blood flow
US20140220580A1 (en) * 2011-06-16 2014-08-07 Kirk Brown Biomarker compositions and methods
US20150282765A1 (en) * 2012-11-06 2015-10-08 Koninklijke Philips N.V. Fractional flow reserve (ffr) index

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01145043A (en) 1987-12-02 1989-06-07 Hitachi Ltd Ultrasonic diagnostic apparatus
US5533511A (en) 1994-01-05 1996-07-09 Vital Insite, Incorporated Apparatus and method for noninvasive blood pressure measurement
JP3641495B2 (en) 1994-07-19 2005-04-20 株式会社日立メディコ Medical diagnostic imaging equipment
US7269516B2 (en) * 2001-05-15 2007-09-11 Psychogenics, Inc. Systems and methods for monitoring behavior informatics
US20030087244A1 (en) * 2001-10-09 2003-05-08 Vitivity, Inc Diagnosis and treatment of vascular disease
US7912528B2 (en) * 2003-06-25 2011-03-22 Siemens Medical Solutions Usa, Inc. Systems and methods for automated diagnosis and decision support for heart related diseases and conditions
US8821408B2 (en) 2006-04-05 2014-09-02 The Regents Of The University Of California Data mining system for noninvasive intracranial pressure assessment
US11064964B2 (en) * 2007-03-08 2021-07-20 Sync-Rx, Ltd Determining a characteristic of a lumen by measuring velocity of a contrast agent
US8098918B2 (en) 2007-09-21 2012-01-17 Siemens Corporation Method and system for measuring left ventricle volume
EP2356579B1 (en) * 2008-10-29 2015-05-20 The Regents of the University of Colorado, a body corporate Long term active learning from large continually changing data sets
WO2011005865A2 (en) * 2009-07-07 2011-01-13 The Johns Hopkins University A system and method for automated disease assessment in capsule endoscopy
WO2011008906A1 (en) * 2009-07-15 2011-01-20 Mayo Foundation For Medical Education And Research Computer-aided detection (cad) of intracranial aneurysms
GB0913930D0 (en) 2009-08-07 2009-09-16 Ucl Business Plc Apparatus and method for registering two medical images
US8224640B2 (en) 2009-09-08 2012-07-17 Siemens Aktiengesellschaft Method and system for computational modeling of the aorta and heart
AU2010298333B2 (en) 2009-09-23 2014-04-17 Lightlab Imaging, Inc. Lumen morphology and vascular resistance measurements data collection systems, apparatus and methods
US20110081057A1 (en) 2009-10-06 2011-04-07 Eigen, Llc Apparatus for stenosis estimation
US20110257545A1 (en) * 2010-04-20 2011-10-20 Suri Jasjit S Imaging based symptomatic classification and cardiovascular stroke risk score estimation
US8682626B2 (en) * 2010-07-21 2014-03-25 Siemens Aktiengesellschaft Method and system for comprehensive patient-specific modeling of the heart
JP5868052B2 (en) 2010-07-21 2016-02-24 シーメンス アクチエンゲゼルシヤフトSiemens Aktiengesellschaft Comprehensive patient-specific heart modeling method and system
US20120142632A1 (en) 2010-08-04 2012-06-07 St. Vincent's Institute Of Medical Research Diagnostic and prognostic assay
US8315812B2 (en) * 2010-08-12 2012-11-20 Heartflow, Inc. Method and system for patient-specific modeling of blood flow
US9119540B2 (en) 2010-09-16 2015-09-01 Siemens Aktiengesellschaft Method and system for non-invasive assessment of coronary artery disease
US8684921B2 (en) * 2010-10-01 2014-04-01 Flint Hills Scientific Llc Detecting, assessing and managing epilepsy using a multi-variate, metric-based classification analysis
GB201100137D0 (en) 2011-01-06 2011-02-23 Davies Helen C S Apparatus and method of assessing a narrowing in a fluid tube
JP5734000B2 (en) 2011-01-31 2015-06-10 株式会社Nttドコモ Object identification system and method, and feature point position extraction system and method
US9245091B2 (en) * 2011-03-09 2016-01-26 Siemens Aktiengesellschaft Physically-constrained modeling of a heart in medical imaging
US10162932B2 (en) 2011-11-10 2018-12-25 Siemens Healthcare Gmbh Method and system for multi-scale anatomical and functional modeling of coronary circulation
US9129053B2 (en) * 2012-02-01 2015-09-08 Siemens Aktiengesellschaft Method and system for advanced measurements computation and therapy planning from medical data and images using a multi-physics fluid-solid heart model
US10373700B2 (en) * 2012-03-13 2019-08-06 Siemens Healthcare Gmbh Non-invasive functional assessment of coronary artery stenosis including simulation of hyperemia by changing resting microvascular resistance
US9135699B2 (en) * 2012-03-15 2015-09-15 Siemens Aktiengesellschaft Method and system for hemodynamic assessment of aortic coarctation from medical image data
EP2863802B1 (en) 2012-06-26 2020-11-04 Sync-RX, Ltd. Flow-related image processing in luminal organs
US10433740B2 (en) * 2012-09-12 2019-10-08 Heartflow, Inc. Systems and methods for estimating ischemia and blood flow characteristics from vessel geometry and physiology
US10398386B2 (en) * 2012-09-12 2019-09-03 Heartflow, Inc. Systems and methods for estimating blood flow characteristics from vessel geometry and physiology
US9424395B2 (en) * 2013-03-04 2016-08-23 Heartflow, Inc. Method and system for sensitivity analysis in modeling blood flow characteristics
US9463072B2 (en) * 2013-08-09 2016-10-11 Siemens Aktiengesellschaft System and method for patient specific planning and guidance of electrophysiology interventions
US9805463B2 (en) * 2013-08-27 2017-10-31 Heartflow, Inc. Systems and methods for predicting location, onset, and/or change of coronary lesions
US9700219B2 (en) * 2013-10-17 2017-07-11 Siemens Healthcare Gmbh Method and system for machine learning based assessment of fractional flow reserve
US9785746B2 (en) 2014-03-31 2017-10-10 Heartflow, Inc. Systems and methods for determining blood flow characteristics using flow ratio
US9888968B2 (en) * 2014-07-22 2018-02-13 Siemens Healthcare Gmbh Method and system for automated therapy planning for arterial stenosis
US9349178B1 (en) 2014-11-24 2016-05-24 Siemens Aktiengesellschaft Synthetic data-driven hemodynamic determination in medical imaging
US10595790B2 (en) * 2014-12-16 2020-03-24 Siemens Healthcare Gmbh Method and system for personalized non-invasive hemodynamic assessment of renal artery stenosis from medical images
US9785748B2 (en) * 2015-07-14 2017-10-10 Heartflow, Inc. Systems and methods for estimating hemodynamic forces acting on plaque and monitoring patient risk
US11087459B2 (en) * 2015-08-14 2021-08-10 Elucid Bioimaging Inc. Quantitative imaging for fractional flow reserve (FFR)
CA3017610C (en) * 2016-03-16 2024-04-30 Heartflow, Inc. Systems and methods for estimating healthy lumen diameter and stenosis quantification in coronary arteries
WO2018222755A1 (en) * 2017-05-30 2018-12-06 Arterys Inc. Automated lesion detection, segmentation, and longitudinal identification
US10650286B2 (en) * 2017-09-07 2020-05-12 International Business Machines Corporation Classifying medical images using deep convolution neural network (CNN) architecture
US10363008B2 (en) * 2017-11-27 2019-07-30 Canon Medical Systems Usa, Inc. Computed tomography perfusion (CTP) method and apparatus using blood flow for discriminating types of cancer
US10699407B2 (en) * 2018-04-11 2020-06-30 Pie Medical Imaging B.V. Method and system for assessing vessel obstruction based on machine learning

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6377832B1 (en) * 1998-03-20 2002-04-23 Georgia Tech Research Corporation System and method for analyzing a medical image
US20050059876A1 (en) * 2003-06-25 2005-03-17 Sriram Krishnan Systems and methods for providing automated regional myocardial assessment for cardiac imaging
US20050005987A1 (en) * 2003-07-12 2005-01-13 Hayes Frank F. Method and apparatus for forming flared tube ends
US20080292049A1 (en) * 2007-05-21 2008-11-27 Estelle Camus Device for obtaining perfusion images
US20090103794A1 (en) * 2007-10-19 2009-04-23 Boston Scientific Scimed, Inc. Display of classifier output and confidence measure in an image
US20120053918A1 (en) * 2010-08-12 2012-03-01 Heartflow, Inc. Method and system for patient-specific modeling of blood flow
US20140220580A1 (en) * 2011-06-16 2014-08-07 Kirk Brown Biomarker compositions and methods
US20150282765A1 (en) * 2012-11-06 2015-10-08 Koninklijke Philips N.V. Fractional flow reserve (ffr) index

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Deng, 1/1/2012, Three Classes of Deep Learning Architectures and Their Applications: A Tutorial Survey, APSIPA Transactions on Signal and Information Processing *
Krizhevesky et al. 2012, ImageNet Classification with Deep Convolution Neural Networks, Conference: Advances in Neural Information Processing Systems 25, p. 1-9 *

Cited By (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11315690B2 (en) 2013-05-10 2022-04-26 Stenomics, Inc. Modeling and simulation system for optimizing prosthetic heart valve treatment
US10497476B2 (en) 2013-05-10 2019-12-03 Stenomics, Inc. Modeling and simulation system for optimizing prosthetic heart valve treatment
US10762442B2 (en) 2013-10-23 2020-09-01 Stenomics, Inc. Machine learning system for assessing heart valves and surrounding cardiovascular tracts
US9953272B2 (en) 2013-10-23 2018-04-24 Stenomics, Inc. Machine learning system for assessing heart valves and surrounding cardiovascular tracts
US11024426B2 (en) 2013-10-23 2021-06-01 Stenomics, Inc. Machine learning system for assessing heart valves and surrounding cardiovascular tracts
US11024425B2 (en) 2013-10-23 2021-06-01 Stenomics, Inc. Machine learning system for assessing heart valves and surrounding cardiovascular tracts
US10943698B2 (en) 2013-10-23 2021-03-09 Stenomics, Inc. Machine learning system for assessing heart valves and surrounding cardiovascular tracts
US20210312622A1 (en) * 2015-08-14 2021-10-07 Elucid Bioimaging Inc. Quantitative imaging for instantaneous wave-free ratio (ifr)
US11607179B2 (en) 2015-08-14 2023-03-21 Elucid Bioimaging Inc. Non-invasive risk stratification for atherosclerosis
US12106477B2 (en) 2015-08-14 2024-10-01 Elucid Bioimaging Inc. Segmenting permeability, neovascularization, necrosis, collagen breakdown, or inflammation to characterize atherosclerotic plaque, coronary artery disease, or vasculopathy
US12073561B2 (en) 2015-08-14 2024-08-27 Elucid Bioimaging Inc. Multiscale modeling to determine molecular profiles from radiology
US12045983B2 (en) 2015-08-14 2024-07-23 Elucid Bioimaging Inc. Functional measures of stenosis significance
US20190172197A1 (en) * 2015-08-14 2019-06-06 Elucid Bioimaging Inc. Methods and systems for utilizing quantitative imaging
US12039765B2 (en) 2015-08-14 2024-07-16 Elucid Bioimaging Inc. Systems and methods for optimizing analysis of CT angiography
US11071501B2 (en) 2015-08-14 2021-07-27 Elucid Bioiwaging Inc. Quantitative imaging for determining time to adverse event (TTE)
US11087459B2 (en) * 2015-08-14 2021-08-10 Elucid Bioimaging Inc. Quantitative imaging for fractional flow reserve (FFR)
US11087460B2 (en) 2015-08-14 2021-08-10 Elucid Bioimaging Inc. Methods and systems for training and validating quantitative imaging biomarkers
US11094058B2 (en) * 2015-08-14 2021-08-17 Elucid Bioimaging Inc. Systems and method for computer-aided phenotyping (CAP) using radiologic images
US11113812B2 (en) 2015-08-14 2021-09-07 Elucid Bioimaging Inc. Quantitative imaging for detecting vulnerable plaque
US11120312B2 (en) 2015-08-14 2021-09-14 Elucid Bioimaging Inc. Quantitative imaging for cancer subtype
US12026868B2 (en) 2015-08-14 2024-07-02 Elucid Bioimaging Inc. Quantitative imaging for detecting histopathologically defined plaque erosion non-invasively
US20210390689A1 (en) * 2015-08-14 2021-12-16 Elucid Bioimaging Inc Non-invasive quantitative imaging biomarkers of atherosclerotic plaque biology
US12008751B2 (en) 2015-08-14 2024-06-11 Elucid Bioimaging Inc. Quantitative imaging for detecting histopathologically defined plaque fissure non-invasively
US11696735B2 (en) * 2015-08-14 2023-07-11 Elucid Bioimaging Inc. Quantitative imaging for instantaneous wave-free ratio
US11676359B2 (en) * 2015-08-14 2023-06-13 Elucid Bioimaging Inc. Non-invasive quantitative imaging biomarkers of atherosclerotic plaque biology
US10483006B2 (en) 2017-05-19 2019-11-19 Siemens Healthcare Gmbh Learning based methods for personalized assessment, long-term prediction and management of atherosclerosis
EP3404667A1 (en) * 2017-05-19 2018-11-21 Siemens Healthcare GmbH Learning based methods for personalized assessment, long-term prediction and management of atherosclerosis
US10959685B2 (en) * 2017-08-03 2021-03-30 Siemens Healthcare Gmbh Ascertaining a function parameter relating to a local tissue function for plurality of tissue regions
US20190038239A1 (en) * 2017-08-03 2019-02-07 Siemens Healthcare Gmbh Ascertaining a function parameter relating to a local tissue function for plurality of tissue regions
US10762637B2 (en) * 2017-10-27 2020-09-01 Siemens Healthcare Gmbh Vascular segmentation using fully convolutional and recurrent neural networks
US20190130074A1 (en) * 2017-10-30 2019-05-02 Siemens Healthcare Gmbh Machine-learnt prediction of uncertainty or sensitivity for hemodynamic quantification in medical imaging
US10522253B2 (en) * 2017-10-30 2019-12-31 Siemens Healthcare Gmbh Machine-learnt prediction of uncertainty or sensitivity for hemodynamic quantification in medical imaging
US11871995B2 (en) 2017-12-18 2024-01-16 Hemolens Diagnostics Sp. Z O.O. Patient-specific modeling of hemodynamic parameters in coronary arteries
US11508063B2 (en) 2019-08-05 2022-11-22 Elucid Bioimaging Inc. Non-invasive measurement of fibrous cap thickness
US11887713B2 (en) 2021-06-10 2024-01-30 Elucid Bioimaging Inc. Non-invasive determination of likely response to anti-diabetic therapies for cardiovascular disease
US11887701B2 (en) 2021-06-10 2024-01-30 Elucid Bioimaging Inc. Non-invasive determination of likely response to anti-inflammatory therapies for cardiovascular disease
US11887734B2 (en) 2021-06-10 2024-01-30 Elucid Bioimaging Inc. Systems and methods for clinical decision support for lipid-lowering therapies for cardiovascular disease
US12100149B2 (en) 2021-06-10 2024-09-24 Elucid Bioimaging Inc. Determining likely response to combination therapies for cardiovascular disease non-invasively
US11869186B2 (en) 2021-06-10 2024-01-09 Elucid Bioimaging Inc. Non-invasive determination of likely response to combination therapies for cardiovascular disease
US12125572B2 (en) 2023-08-09 2024-10-22 Elucid Bioimaging Inc. Determining likely response to anti-inflammatory and pro-resolving therapies for cardiovascular disease non-invasively
US12125571B2 (en) 2023-08-09 2024-10-22 Elucid Bioimaging Inc. Determining likely response to glycemic treatment for cardiovascular disease non-invasively
US12131472B2 (en) 2023-11-08 2024-10-29 Elucid Bioimaging Inc. Non-invasive imaging to determine health and disease
US12131471B2 (en) 2023-11-08 2024-10-29 Elucid Bioimaging Inc. Longitudinal change measures for optimizing patient care

Also Published As

Publication number Publication date
US20150245775A1 (en) 2015-09-03
US10433740B2 (en) 2019-10-08
US11013425B2 (en) 2021-05-25
US20160317046A1 (en) 2016-11-03
US20160310019A1 (en) 2016-10-27
US20220322953A1 (en) 2022-10-13
US20170281011A1 (en) 2017-10-05
US20160317114A1 (en) 2016-11-03
US20160310096A1 (en) 2016-10-27
US10561324B2 (en) 2020-02-18
US10010255B2 (en) 2018-07-03
US20200359910A1 (en) 2020-11-19
US10966619B2 (en) 2021-04-06
US20160321417A1 (en) 2016-11-03
US20190380591A1 (en) 2019-12-19
US9974453B2 (en) 2018-05-22
US20180235482A1 (en) 2018-08-23
US20140073976A1 (en) 2014-03-13
US11399729B2 (en) 2022-08-02

Similar Documents

Publication Publication Date Title
US11013425B2 (en) Systems and methods for analyzing and processing digital images to estimate vessel characteristics
US11382569B2 (en) Systems and methods for estimating blood flow characteristics from vessel geometry and physiology
US20230306596A1 (en) Systems and methods for processing electronic images to predict lesions

Legal Events

Date Code Title Description
AS Assignment

Owner name: HEARTFLOW, INC., DISTRICT OF COLUMBIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:FONTE, TIMOTHY;CHOI, GILWOO;GRADY, LEO;AND OTHERS;SIGNING DATES FROM 20120103 TO 20130904;REEL/FRAME:039066/0613

STPP Information on status: patent application and granting procedure in general

Free format text: FINAL REJECTION MAILED

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION

AS Assignment

Owner name: HAYFIN SERVICES LLP, UNITED KINGDOM

Free format text: SECURITY INTEREST;ASSIGNOR:HEARTFLOW, INC.;REEL/FRAME:055037/0890

Effective date: 20210119

AS Assignment

Owner name: HEARTFLOW, INC., CALIFORNIA

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:HAYFIN SERVICES LLP;REEL/FRAME:067801/0032

Effective date: 20240614